Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.1283838572124486e-43,28.212820512820514,2789.976332739789,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.070705151802974e-41,0,0,74
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.791067523390956e-12,4.76349905092686,124.15711523482938,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",1.2887971637921672e-09,0,0,43
3,Oxidative phosphorylation WP623,7.929192951480342e-07,4.303083700440529,60.44775930467438,"['ATP5PF', 'NDUFA8', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'ATP6AP1', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB4', 'NDUFA3', 'ATP6AP2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS5', 'ATP5MF', 'ATP5ME']",0.0001283924820748184,0,0,24
4,Nonalcoholic fatty liver disease WP4396,9.545909447941888e-07,2.6040144826271994,36.09680427714146,"['CEBPA', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'ADIPOR1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'BBC3', 'LEPR', 'UQCRFS1', 'CYC1', 'RAC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'TNFRSF1A', 'UQCRQ', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",0.0001283924820748184,0,0,45
5,Glycolysis and Gluconeogenesis WP534,1.2116024743878435e-06,6.319077058207493,86.088367883174,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A3', 'ENO1', 'ENO2', 'LDHA', 'PFKL', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",0.00013036842624413196,0,0,17
6,"GPCRs, Class A Rhodopsin-like WP455",6.066077197366852e-06,3.1215011037527596,37.49796353511704,"['GPR27', 'OXTR', 'CHRM1', 'GPR87', 'GPR22', 'CHRM5', 'OPRL1', 'GPR83', 'ADRB1', 'ADRA1D', 'MCHR1', 'LTB4R', 'GPR171', 'P2RY12', 'GPR39', 'GPR12', 'P2RY14', 'SSTR1', 'GPR6', 'ADRA2C', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'ADORA2A', 'LPAR6', 'FSHR', 'ACKR4', 'OR6A2']",0.000543924922030561,0,0,29
7,Mitochondrial CIV Assembly WP4922,2.124407432979281e-05,4.8287971905179985,51.9551177006352,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX7C', 'COX6B1', 'TMEM177', 'SCO2', 'COX14']",0.0016327588556326476,0,0,16
8,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0003790463833228354,2.959447004608295,23.314085435880507,"['NDUFA8', 'NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",0.02549086927846068,0,0,19
9,Myometrial relaxation and contraction pathways WP289,0.0004871374807750277,2.065936794826116,15.756825918513593,"['RYR1', 'OXTR', 'RGS14', 'YWHAB', 'ITPR2', 'ATP2A2', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'IGFBP6', 'NOS1', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'IGFBP3', 'IGFBP2', 'PRKCD', 'FOS', 'ACTA2', 'CREB3', 'CACNB3', 'ACTC1', 'PRKAR1A', 'PRKCQ', 'CALM3', 'ATF5', 'CALM1', 'CALM2']",0.0291199960729961,0,0,35
10,Selenium Micronutrient Network WP15,0.0006458431617701584,2.8961335676625657,21.27196744800868,"['GPX4', 'HBA1', 'KMO', 'SELENOK', 'SOD2', 'SELENOH', 'SOD1', 'PRDX3', 'SELENOM', 'PRDX5', 'SELENOS', 'RFK', 'PRDX1', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2', 'MSRB1']",0.03199262513879252,0,0,18
11,Nuclear Receptors Meta-Pathway WP2882,0.0007281630940721598,1.7536828525625825,12.670333189324547,"['CDKN1B', 'HSP90AB1', 'SRXN1', 'KEAP1', 'SLC2A3', 'RGS2', 'FTH1', 'ENC1', 'SLC39A6', 'CYP1B1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A3', 'CBR1', 'ABCG8', 'G6PD', 'HSP90AA1', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'NRG1', 'CDC37', 'B3GNT5', 'FKBP5', 'FTL', 'ABCB1', 'GSTP1', 'AMIGO2', 'PDGFB', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'PTPA', 'DNAJB1', 'PRDX1', 'GSTM4', 'EGR1', 'JUN', 'JUND', 'GADD45B', 'SLC10A1', 'PLK2', 'SLC2A9', 'SLC6A6', 'PSMC5', 'BHLHE40', 'BAX', 'SPRY1', 'HSPA1A']",0.03199262513879252,0,0,51
12,Computational Model of Aerobic Glycolysis WP4629,0.0007730559977775144,8.426322693484915,60.37594247276021,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.03199262513879252,0,0,7
13,Glycolysis in senescence WP5049,0.0007730559977775144,8.426322693484915,60.37594247276021,"['LDHA', 'G6PD', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.03199262513879252,0,0,7
14,miR-517 relationship with ARCN1 and USP1 WP3596,0.0008804617466634288,inf,inf,"['CDKN1A', 'ID2', 'USP1', 'ARCN1']",0.03383488712178034,0,0,4
15,Metabolic reprogramming in colon cancer WP4290,0.0013260970988459363,3.0144800351031154,19.972483181188068,"['G6PD', 'MDH2', 'PGAM1', 'GOT2', 'PYCR2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PFKL', 'PKM', 'PGK1', 'ALDOB', 'SLC16A3', 'GAPDH']",0.04756268261194092,0,0,15
16,Mitochondrial complex III assembly WP4921,0.0015678008892997652,5.503812023497063,35.544065777249266,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.052717304902704605,0,0,8
17,NRF2 pathway WP2884,0.0020790195260872945,2.093298059964727,12.927913408127981,"['HSP90AB1', 'SRXN1', 'GSTP1', 'PDGFB', 'KEAP1', 'SLC2A3', 'SLC5A3', 'DNAJB1', 'FTH1', 'PRDX1', 'SLC39A6', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'GSTM4', 'EGR1', 'CBR1', 'G6PD', 'HSP90AA1', 'SLC2A12', 'SLC39A11', 'NRG1', 'SLC2A9', 'SLC6A6', 'FTL', 'HSPA1A']",0.06579485323735085,0,0,26
18,Proximal tubule transport WP4917,0.0029138680138311944,2.983966931796831,17.4212161550583,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'ABCB1', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.0825375035933697,0,0,13
19,Cori Cycle WP1946,0.002914893249579971,5.616528202885877,32.78885401374067,"['G6PD', 'LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.0825375035933697,0,0,7
20,Senescence and Autophagy in Cancer WP615,0.0036048040101034702,2.0949045803112254,11.784860317608727,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'BMI1', 'GABARAP', 'RSL1D1', 'MAP1LC3B', 'MAP1LC3A', 'LAMP1', 'FKBP8', 'E2F1', 'SLC39A1', 'HRAS', 'SLC39A3']",0.09696922787178335,0,0,23
21,Vitamin D Receptor Pathway WP2877,0.004608498885735222,2.0818661971830985,11.200134307029613,"['CDKN2D', 'CEBPA', 'G6PD', 'CDKN1A', 'ABCB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'IGFBP3', 'CYP3A5', 'CEACAM1', 'BGLAP', 'CREG2', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'PRKCQ', 'CLPTM1L', 'JUNB']",0.11806535240597855,0,0,22
22,IL-18 signaling pathway WP4754,0.0050824173998041695,1.6127167630057804,8.518318761786496,"['CEBPB', 'NRN1', 'STOML1', 'CD81', 'MEPCE', 'COX17', 'HSPB1', 'ENO1', 'ACACB', 'FUT1', 'CENPB', 'PTMS', 'IRAK1', 'TMSB4X', 'STMN1', 'TIMP3', 'RPS11', 'IER3', 'MAPK3', 'SLC12A3', 'JUN', 'USP5', 'BAD', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'DEK', 'EEF2', 'TNFRSF1A', 'ACTA2', 'NR4A1', 'ARL4D', 'UCK1', 'NACA', 'RFX5', 'CYCS', 'BAX', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.12428820732248377,0,0,45
23,Apoptosis Modulation and Signaling WP1772,0.006285944323572024,2.097434132537953,10.63281480641094,"['DAXX', 'JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'BNIP3', 'FOS', 'BBC3', 'TNFRSF1A', 'CAPNS1', 'IRAK1', 'CASP6', 'TOLLIP', 'PEA15', 'CYCS', 'BAX', 'BCL2L2', 'MAPK3', 'HSPA1A']",0.14687532674887774,0,0,20
24,Zinc homeostasis WP3529,0.006552059185823541,3.85161854768154,19.365845230757778,"['SLC30A3', 'SLC39A6', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A3']",0.14687532674887774,0,0,8
25,Translation Factors WP107,0.007850157113922035,2.2686567164179103,10.996682140255423,"['EIF4A2', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF3CL', 'EIF4B']",0.16641003824211126,0,0,16
26,VEGFA-VEGFR2 Signaling Pathway WP3888,0.008042120807239577,1.3831393239691196,6.670967334590678,"['RPL5', 'ARPC5L', 'HSPB1', 'NRARP', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'CHAC1', 'RAC1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'DUSP5', 'HSP90AA1', 'PDPK1', 'IGFBP3', 'PRKCD', 'RPS6', 'RPL13A', 'EPN1', 'RCN1', 'RAB37', 'KATNAL2', 'MAPKAPK2', 'FSCN1', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'FJX1', 'ARF6', 'LRRC59', 'SET', 'NOTCH4', 'CRIP2', 'FOXO4', 'ACACB', 'NDRG1', 'FUT1', 'APOLD1', 'PPP2CA', 'STIP1', 'SDCBP', 'LDHA', 'DNAJB4', 'PGK1', 'DNAJB9', 'CCT7', 'ABCF2', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'FN1', 'SOD2', 'RAB11A', 'DNAJA1', 'NR4A1', 'NR4A3', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'HSPA1A']",0.16641003824211126,0,0,81
27,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.009831017121437358,9.619213973799127,44.46205471576742,"['HSD11B1', 'HSD11B2', 'H6PD', 'STAR']",0.1910945425920673,0,0,4
28,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.010655829512568807,3.0952797749296654,14.057671708447934,"['RAB3B', 'EGR2', 'RAB3A', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'NDRG1', 'RAB11A']",0.1910945425920673,0,0,9
29,Pre-implantation embryo WP3527,0.010655829512568807,3.0952797749296654,14.057671708447934,"['EGR1', 'BATF3', 'ARGFX', 'DDIT3', 'AQP9', 'HMGA1', 'FOSB', 'ATP1A1', 'HNRNPAB']",0.1910945425920673,0,0,9
30,Sleep regulation WP3591,0.010655829512568807,3.0952797749296654,14.057671708447934,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'GHRL', 'FOS', 'HCRTR2']",0.1910945425920673,0,0,9
31,Spinal Cord Injury WP2431,0.013568897611828381,1.875494940607127,8.064581442738458,"['RTN4R', 'EGR1', 'CDKN1B', 'GADD45A', 'MIF', 'FOS', 'RTN4', 'LTB4R', 'TNFSF13B', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'ACAN', 'VCAN', 'APEX1', 'E2F1', 'NOS1', 'RAC1', 'ROS1', 'MAPK3']",0.23169921570970053,0,0,21
32,Aryl Hydrocarbon Receptor Pathway WP2873,0.014492393897224202,2.8886652078774615,12.230987846991129,"['HSP90AA1', 'JUN', 'CDKN1B', 'JUND', 'CDC37', 'AIP', 'CYP1B1', 'BAX', 'JUNB']",0.23169921570970053,0,0,9
33,Photodynamic therapy-induced unfolded protein response WP3613,0.014492393897224202,2.8886652078774615,12.230987846991129,"['PPP1R15A', 'NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1', 'BBC3']",0.23169921570970053,0,0,9
34,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.014684371970514346,1.9721201469883367,8.324262899475704,"['HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'TUBB2A', 'TUBB3', 'PSMD2', 'PSMD3', 'STUB1', 'HSPA1B', 'HSPA1A']",0.23169921570970053,0,0,18
35,G1 to S cell cycle control WP45,0.015176551997499187,2.1259324265028523,8.903412812773631,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'CDKN2A', 'GADD45A', 'CCNA1', 'CREB3', 'CCNE2', 'TFDP2', 'RPA3', 'CCNG2', 'MCM3', 'E2F1', 'MCM4']",0.23169921570970053,0,0,15
36,Calcium Regulation in the Cardiac Cell WP536,0.015504036738939068,1.6455187921619017,6.856308863028706,"['RYR1', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'CHRM5', 'ITPR2', 'ATP2A2', 'ADRB1', 'ADRA1D', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'YWHAG', 'YWHAH', 'PRKCH', 'PRKCD', 'ATP1B1', 'GJD2', 'FKBP1A', 'SLC8A3', 'CACNB3', 'PRKAR1A', 'PRKCQ', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.23169921570970053,0,0,30
37,Exercise-induced Circadian Regulation WP410,0.01613575607045941,2.1758630447085454,8.979172312095786,"['DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'GSTP1', 'NCOA4', 'GFRA1', 'HERPUD1', 'PER2', 'DNAJA1', 'TUBB3', 'STBD1', 'SUMO3', 'EIF4G2']",0.23462261529478817,0,0,14
38,Transcriptional cascade regulating adipogenesis WP4211,0.01775896382857834,4.81039755351682,19.39006258667916,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.2457571291813791,0,0,5
39,Nucleotide GPCRs WP80,0.017815107877460566,14.423832387603667,58.09499122133017,"['ADORA2A', 'LPAR6', 'LTB4R']",0.2457571291813791,0,0,3
40,HIF1A and PPARG regulation of glycolysis WP2456,0.019823116288805644,6.412227074235808,25.14174302602568,"['LDHA', 'TPI1', 'PPARG', 'GAPDH']",0.2666209140844359,0,0,4
41,Melanoma WP4685,0.02210924275527295,1.9052098334201468,7.262201746179757,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'MITF', 'FOS', 'ELK1', 'GADD45G', 'E2F1', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.28514040764716325,0,0,17
42,Imatinib and Chronic Myeloid Leukemia WP3640,0.022260031823756236,3.6083916083916083,13.729794767863716,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1', 'PIM2']",0.28514040764716325,0,0,6
43,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.02437907874877749,2.407180385288967,8.94034002871704,"['LDHA', 'PFKL', 'ANGPT2', 'PKM', 'IGFBP3', 'BNIP3', 'IGFBP2', 'PGK1', 'BAX', 'SLC2A3']",0.3050219620195881,0,0,10
44,Genotoxicity pathway WP4286,0.02822106776661894,1.9833333333333334,7.075911550486656,"['PLK3', 'CDKN1A', 'GADD45A', 'EI24', 'PCDH8', 'TRIAP1', 'ACTA2', 'RPS27', 'RRM2B', 'BLOC1S2', 'ID2', 'B3GNT2', 'TRIM22', 'PHLDA3']",0.3450666922372952,0,0,14
45,Kynurenine Pathway and links to Cellular Senescence WP5044,0.03180407106636332,3.207167832167832,11.058830963759291,"['CDKN1A', 'TDO2', 'HAAO', 'NOS1', 'KMO', 'ACMSD']",0.3802353385267437,0,0,6
46,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.03931983220731101,1.8728070175438596,6.060452671968775,"['FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'SOD1', 'PPP2CA', 'TMSB4X', 'NEFL', 'NEFM', 'NOS1', 'NEFH', 'PFN2']",0.4598710810333331,0,0,14
47,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.04134129633133028,3.435374149659864,10.944735718018148,"['CD63', 'CD81', 'HSPB1', 'ETS2', 'SOD1']",0.4633670297136603,0,0,5
48,Galanin receptor pathway WP4970,0.04134129633133028,3.435374149659864,10.944735718018148,"['CDKN1A', 'CDKN1B', 'PRKCD', 'PPARG', 'FOS']",0.4633670297136603,0,0,5
49,Androgen receptor signaling pathway WP138,0.04420462453832846,1.63334973093034,5.094296726975179,"['CDKN1A', 'DAXX', 'JUN', 'LIMK2', 'NCOA4', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'AR', 'KAT5', 'PRDX1', 'BAG1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.4853487347269533,0,0,20
50,Amyotrophic lateral sclerosis (ALS) WP2447,0.04616816041275697,2.0926292545496077,6.4358077939501745,"['DAXX', 'BAD', 'NEFL', 'BAX', 'NEFM', 'NOS1', 'RAC1', 'NEFH', 'SOD1', 'TNFRSF1A']",0.49676940604126496,0,0,10
51,Vitamin A and carotenoid metabolism WP716,0.049628211865768344,2.1655142231947484,6.503463261805315,"['ABCG8', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'ALDH1A1', 'LPL', 'BCO1']",0.5235289800741837,0,0,9
52,Aryl Hydrocarbon Receptor Netpath WP2586,0.05113004070361826,1.9610162067455104,5.830852396603428,"['CDKN1A', 'HSP90AA1', 'KLF6', 'CDKN1B', 'PSRC1', 'CDC37', 'E2F1', 'AIP', 'LPL', 'CYP1B1', 'HRAS']",0.5245731001703663,0,0,11
53,Cell cycle WP179,0.05185537702185886,1.539409951563188,4.555570706899387,"['CDKN2D', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'GADD45B', 'GADD45A', 'YWHAB', 'CDKN2A', 'ANAPC11', 'GADD45G', 'MAD2L2', 'CCNA1', 'RBL1', 'PTTG1', 'CCNE2', 'TFDP2', 'MCM3', 'E2F1', 'MCM4', 'YWHAG', 'SKP1', 'YWHAH']",0.5245731001703663,0,0,23
54,Tryptophan metabolism WP465,0.05297696127736523,2.26421697287839,6.652038862194635,"['ECHS1', 'TDO2', 'HAAO', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.5245731001703663,0,0,8
55,Pathways in clear cell renal cell carcinoma WP4018,0.0536273615415802,1.635888848360248,4.7861132386454734,"['TPI1', 'BHLHE41', 'PDGFB', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'ACLY', 'LDHA', 'PFKL', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'KCNJ2', 'BAP1']",0.5245731001703663,0,0,18
56,TP53 network WP1742,0.05789878800917323,3.0056793359545653,8.563357243552446,"['CDKN1A', 'CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.5467695133824902,0,0,5
57,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.057929112012643016,2.623569612205976,7.473330449358971,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF3CL', 'EIF1']",0.5467695133824902,0,0,6
58,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.060449276966842776,2.0622069396686467,5.7864509292747135,"['PRKCH', 'STAR', 'FSHR', 'PRKCD', 'PRKCQ', 'AMH', 'HRAS', 'PLCB2', 'MAPK3']",0.5607191553131279,0,0,9
59,Adipogenesis WP236,0.06325942450742376,1.5141599597585513,4.1798554645228965,"['FZD1', 'GDF10', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'GADD45A', 'ASIP', 'HMGA1', 'LPL', 'MIF', 'BSCL2', 'BMP3', 'CYP26B1', 'KLF6', 'RBL1', 'DDIT3', 'E2F1', 'NDN', 'PPARG', 'MEF2D']",0.5704145574784673,0,0,22
60,Glucocorticoid Receptor Pathway WP2880,0.06447374182927222,1.8049956178790534,4.948390507319926,"['RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40', 'SPRY1']",0.5704145574784673,0,0,12
61,Complement system WP2806,0.06635825891946971,1.9248686514886164,5.221566265579922,"['SELP', 'PRNP', 'FKBP2', 'GNA15', 'RPS19', 'C1QBP', 'F12', 'SERPING1', 'CD59', 'CALR']",0.5704145574784673,0,0,10
62,Alzheimer's disease WP2059,0.06669435784708719,1.6051822573561705,4.346247532399614,"['PSENEN', 'ATP5MD', 'BAD', 'ATP2A2', 'ITPR2', 'LPL', 'TNFRSF1A', 'APH1A', 'CYCS', 'CALM3', 'NOS1', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.5704145574784673,0,0,17
63,Cellular Proteostasis WP4918,0.06785600683758718,4.807071147970318,12.932787340057935,"['VBP1', 'PFDN5', 'PFDN6']",0.5704145574784673,0,0,3
64,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.06785600683758718,4.807071147970318,12.932787340057935,"['CEBPB', 'ALDH1A1', 'ADH5']",0.5704145574784673,0,0,3
65,Gastrin signaling pathway WP4659,0.07697388957885697,1.4874615046194457,3.814281190600673,"['CHGA', 'EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'ELK1', 'RHOB', 'KAT5', 'PRKCQ', 'PPARG', 'RAC1', 'HRAS', 'MEF2D', 'MAPK3']",0.6331892360886492,0,0,21
66,Glycogen Synthesis and Degradation WP500,0.07827660196866508,1.8506668462885625,4.714585905523561,"['PPP2CA', 'GYS2', 'PTPA', 'GYS1', 'GSK3A', 'PPP2R1A', 'PHKA1', 'CALM3', 'CALM1', 'CALM2']",0.6331892360886492,0,0,10
67,Effects of nitric oxide WP1995,0.07885442159468307,9.611692844677139,24.415159756260376,"['HBA1', 'NOS1']",0.6331892360886492,0,0,2
68,Pathogenic Escherichia coli infection WP2272,0.08259471105052123,1.7644327639071398,4.400159420537523,"['TUBB8', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB', 'ARPC5L', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'ACTG1']",0.653469919782065,0,0,11
69,Circadian rhythm related genes WP3594,0.09059364135703803,1.3409910429400684,3.2202173398309544,"['MAGEL2', 'AHCY', 'CHRM1', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'CCAR2', 'PPP1CC', 'DBP', 'UBC', 'RPS27A', 'SKP1', 'CHRNB2', 'KLF10', 'EGR1', 'JUN', 'EGR3', 'JUND', 'USP2', 'CARTPT', 'HCRTR2', 'NR2F6', 'PER2', 'STAR', 'ADORA2A', 'ID2', 'BHLHE40', 'PPARG', 'GHRL', 'ATF5', 'UBA52']",0.7063678123200936,0,0,32
70,Monoamine GPCRs WP58,0.09385657857525267,2.219540075309306,5.251403900155825,"['CHRM1', 'CHRM5', 'ADRB1', 'ADRA1D', 'HTR5A', 'ADRA2C']",0.7090893987685163,0,0,6
71,Breast cancer pathway WP4262,0.09949789025754091,1.39266493285919,3.2137398347621806,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'GADD45A', 'NOTCH4', 'WNT7A', 'FOS', 'FGF1', 'GADD45G', 'DLL3', 'FRAT1', 'FGF7', 'FRAT2', 'HEY1', 'CSNK2B', 'E2F1', 'BAX', 'WNT2', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.7090893987685163,0,0,24
72,Ferroptosis WP4313,0.10134845491746819,1.8039387308533916,4.129559678039495,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'NCOA4', 'ACSL5', 'FTL']",0.7090893987685163,0,0,9
73,Bile acids synthesis and enterohepatic circulation  WP4389,0.10388070592348296,3.6049759930161502,8.16351174429572,"['ABCG8', 'SLC10A1', 'MAPK3']",0.7090893987685163,0,0,3
74,NAD Biosynthesis II (from tryptophan) WP2485,0.10388070592348296,3.6049759930161502,8.16351174429572,"['TDO2', 'HAAO', 'KMO']",0.7090893987685163,0,0,3
75,Osteoblast Signaling WP322,0.10388070592348296,3.6049759930161502,8.16351174429572,"['BGLAP', 'PDGFB', 'PTH1R']",0.7090893987685163,0,0,3
76,PI3K-Akt signaling pathway WP4172,0.10466975651212422,1.2640344128896641,2.8528562255619954,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMA2', 'FLT3', 'LAMA4', 'LAMA3', 'PDGFB', 'FGF1', 'THBS4', 'HSP90B1', 'GYS2', 'PPP2CA', 'GYS1', 'GNG10', 'FGF7', 'GNG3', 'PPP2R1A', 'PDGFD', 'RAC1', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'ITGA4', 'PDPK1', 'BAD', 'RPS6', 'FN1', 'EPOR', 'EFNA1', 'CREB3', 'EFNA3', 'CCNE2', 'LPAR6', 'IL7', 'CDC37', 'ITGA10', 'ITGA8', 'COL6A6', 'FGF10']",0.7090893987685163,0,0,43
77,Peptide GPCRs WP24,0.10487113640657167,1.980323567993004,4.465675103871293,"['OXTR', 'FSHR', 'OPRL1', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2']",0.7090893987685163,0,0,7
78,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.10544080279085745,2.7470991890205863,6.179889704362809,"['JAG1', 'E2F1', 'TULP3', 'SOX4']",0.7090893987685163,0,0,4
79,Hypertrophy Model WP516,0.10544080279085745,2.7470991890205863,6.179889704362809,"['JUND', 'NR4A3', 'WDR1', 'IL18']",0.7090893987685163,0,0,4
80,RalA downstream regulated genes WP2290,0.10544080279085745,2.7470991890205863,6.179889704362809,"['EXOC8', 'RAC3', 'RAC1', 'HRAS']",0.7090893987685163,0,0,4
81,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.11541463352461948,2.060814185814186,4.449759709161565,"['G6PD', 'GOT1', 'MDH2', 'SCO2', 'GOT2', 'HMGA1']",0.766581146126485,0,0,6
82,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.11944591178215588,1.2495559502664297,2.6551709813676156,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMA2', 'LAMA4', 'LAMA3', 'PDGFB', 'SLC2A3', 'FGF1', 'THBS4', 'HSP90B1', 'GYS2', 'PPP2CA', 'GYS1', 'GNG10', 'FGF7', 'GNG3', 'PPP2R1A', 'PDGFD', 'NOS1', 'PELO', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'ITGA4', 'PDPK1', 'BAD', 'RPS6', 'FN1', 'EPOR', 'EFNA1', 'CREB3', 'EFNA3', 'RAB14', 'LPAR6', 'CDC37', 'ITGA10', 'ITGA8', 'FGF10']",0.7836817138878032,0,0,42
83,Pregnane X receptor pathway WP2876,0.12654912847446514,2.1853528734262677,4.517396856595275,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A5', 'CYP3A7']",0.8202823026417138,0,0,5
84,CAMKK2  Pathway WP4874,0.13142146617337136,1.748826851189056,3.548974462428064,"['FIS1', 'MAP1LC3A', 'WFS1', 'NOS1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.8417232000151642,0,0,8
85,Major receptors targeted by epinephrine and norepinephrine WP4589,0.13749057076670146,2.4034934497816596,4.769011559974738,"['ADCY10', 'ADRB1', 'ADRA1D', 'ADRA2C']",0.8650902806722751,0,0,4
86,Cells and molecules involved in local acute inflammatory response  WP4493,0.1398937814470036,4.805410122164049,9.451625888744934,"['SELP', 'ITGA4']",0.8650902806722751,0,0,2
87,Irinotecan pathway WP229,0.1398937814470036,4.805410122164049,9.451625888744934,"['ABCC1', 'CYP3A5']",0.8650902806722751,0,0,2
88,IL1 and megakaryocytes in obesity WP2865,0.14562962209298413,2.883718900043649,5.55602866330614,"['IRAK1', 'IL18', 'TIMP2']",0.869283909493209,0,0,3
89,Trans-sulfuration pathway WP2333,0.14562962209298413,2.883718900043649,5.55602866330614,"['AHCY', 'GOT1', 'MAT2B']",0.869283909493209,0,0,3
90,Folate Metabolism WP176,0.14703501071353534,1.7715462683819299,3.396203985050624,"['AHCY', 'GPX4', 'RFK', 'NOS1', 'HBA1', 'SOD2', 'SOD1']",0.869283909493209,0,0,7
91,Oxidation by Cytochrome P450 WP43,0.14703501071353534,1.7715462683819299,3.396203985050624,"['CYP27A1', 'CYP39A1', 'CYP26B1', 'CYP1B1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.869283909493209,0,0,7
92,Purinergic signaling WP4900,0.15514081093649656,2.003058103975535,3.7325427721954725,"['P2RY12', 'GNAZ', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9036206090942994,0,0,5
93,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.15620207554975807,1.5514660188689904,2.880459186137623,"['CDKN1A', 'FGF7', 'HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'FOS', 'ELK1', 'JUNB', 'TNFRSF1A']",0.9036206090942994,0,0,10
94,Pyrimidine metabolism WP4022,0.1635426708216364,1.3632850241545893,2.4684747530792497,"['RRM2', 'NME2', 'NME1', 'POLE4', 'POLD4', 'UCK1', 'RRM2B', 'POLD2', 'POLE3', 'POLR2E', 'POLR1E', 'CMPK2', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2K', 'POLR2L']",0.9347865631762491,0,0,17
95,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.16506454182480235,1.8028846153846154,3.247750094334974,"['PPP2CA', 'CDKN1A', 'RBL1', 'THRA', 'PTH1R', 'MAPK3']",0.9347865631762491,0,0,6
96,Prostaglandin Synthesis and Regulation WP98,0.17069267025610646,1.6828159160472234,2.975034421731661,"['HSD11B1', 'HSD11B2', 'CBR1', 'S100A6', 'MITF', 'PPARG', 'PTGES']",0.9467284185338688,0,0,7
97,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.17069267025610646,1.6828159160472234,2.975034421731661,"['CREB3', 'STAR', 'ITPR2', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.9467284185338688,0,0,7
98,7q11.23 copy number variation syndrome WP4932,0.1848360793918794,1.3059591836734694,2.204832481029018,"['HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'NRG1', 'DEK', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'DNAJC30', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'GAPDH', 'MAPK3']",0.9912606708971392,0,0,19
99,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.18609168728738115,1.848808683671069,3.1088009837805184,"['H3F3B', 'H2AFZ', 'H2AFV', 'DUSP6', 'MAPK3']",0.9912606708971392,0,0,5
100,Nucleotide metabolism WP404,0.18609168728738115,1.848808683671069,3.1088009837805184,"['PRPS1', 'RRM2', 'RRM2B', 'NME2', 'OAZ1']",0.9912606708971392,0,0,5
101,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.18609168728738115,1.848808683671069,3.1088009837805184,"['JUN', 'SRXN1', 'GSTP1', 'KEAP1', 'FOS']",0.9912606708971392,0,0,5
102,Matrix Metalloproteinases WP129,0.1917076502268749,2.4028808380619817,3.9690394552738564,"['MMP15', 'TIMP2', 'TIMP3']",0.9929967546140481,0,0,3
103,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.1917076502268749,2.4028808380619817,3.9690394552738564,"['JUN', 'PRKCQ', 'MAPK3']",0.9929967546140481,0,0,3
104,Small cell lung cancer WP4658,0.19195476297371933,1.3190672503435477,2.177114619227147,"['CDKN1A', 'CDKN1B', 'LAMA2', 'GADD45B', 'GADD45A', 'LAMA4', 'LAMA3', 'FN1', 'FHIT', 'CKS1B', 'GADD45G', 'CCNE2', 'CKS2', 'E2F1', 'CYCS', 'BAX', 'SKP1']",0.9929967546140481,0,0,17
105,p38 MAPK Signaling Pathway WP400,0.1968669792693589,1.5385476815398076,2.5004892489056805,"['DAXX', 'DDIT3', 'MAPKAPK2', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D']",0.9954479449328998,0,0,8
106,Parkinson's disease pathway WP2371,0.1968669792693589,1.5385476815398076,2.5004892489056805,"['PINK1', 'UBB', 'CCNE2', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9954479449328998,0,0,8
107,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.20279620777788387,1.346701754385965,2.148734976110779,"['CDKN1A', 'JUN', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'FOS', 'BBC3', 'GADD45G', 'RAC3', 'CYCS', 'BAX', 'RAC1', 'MAPK3']",0.9954479449328998,0,0,14
108,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.20726066076806965,3.2033158813263527,5.041308212019902,"['PPARG', 'CYP2C18']",0.9954479449328998,0,0,2
109,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.20726066076806965,3.2033158813263527,5.041308212019902,"['CDKN1A', 'ABCB1']",0.9954479449328998,0,0,2
110,Acute viral myocarditis WP4298,0.20986035685165072,1.373982721923125,2.145216998714834,"['ENDOG', 'LAMA2', 'CASP6', 'RAC3', 'CYCS', 'BAX', 'NOS1', 'ACTB', 'SGCG', 'MICA', 'EIF4G2', 'MAPK3']",0.9954479449328998,0,0,12
111,Oncostatin M Signaling Pathway WP2374,0.20986035685165072,1.373982721923125,2.145216998714834,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'PRKCD', 'RPS6', 'TIMP3', 'FOS', 'JUNB', 'HRAS', 'MAPK3']",0.9954479449328998,0,0,12
112,Differentiation of white and brown adipocyte WP2895,0.2109313489263022,1.9224454148471615,2.9917529230046336,"['CEBPA', 'CEBPB', 'EBF3', 'PPARG']",0.9954479449328998,0,0,4
113,MAPK pathway in congenital thyroid cancer WP4928,0.2109313489263022,1.9224454148471615,2.9917529230046336,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.9954479449328998,0,0,4
114,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2109313489263022,1.9224454148471615,2.9917529230046336,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.9954479449328998,0,0,4
115,Canonical and non-canonical Notch signaling WP3845,0.21903280047423668,1.7165948948386693,2.606707345589979,"['JAG1', 'MAML2', 'HEY1', 'NOTCH4', 'DLL3']",0.9986410733486385,0,0,5
116,Gastric Cancer Network 1 WP2361,0.21903280047423668,1.7165948948386693,2.606707345589979,"['CCNA1', 'ACTL6A', 'MCM4', 'GATD3B', 'GATD3A']",0.9986410733486385,0,0,5
117,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.21903280047423668,1.7165948948386693,2.606707345589979,"['LDHA', 'RPS6', 'KEAP1', 'PDHB', 'ACACB']",0.9986410733486385,0,0,5
118,Striated Muscle Contraction Pathway WP383,0.21903280047423668,1.7165948948386693,2.606707345589979,"['ACTA2', 'MYOM1', 'MYBPC1', 'ACTC1', 'ACTG1']",0.9986410733486385,0,0,5
119,Cell migration and invasion through p75NTR WP4561,0.22205907166312067,1.6022727272727273,2.4111189772100725,"['EFNA1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'RAC1']",0.9998617840333556,0,0,6
120,DNA damage response WP707,0.22916804197724763,1.341907343619428,1.977031736127274,"['CDKN1A', 'CDKN1B', 'RRM2B', 'CCNE2', 'GADD45B', 'GADD45A', 'E2F1', 'CYCS', 'BAX', 'BBC3', 'GADD45G', 'RAD9A']",0.9998617840333556,0,0,12
121,Development and heterogeneity of the ILC family WP3893,0.2407466337964126,2.0594250795036477,2.9326423410876847,"['IL7', 'ID2', 'IL18']",0.9998617840333556,0,0,3
122,Dopamine metabolism WP2436,0.2407466337964126,2.0594250795036477,2.9326423410876847,"['PPP2CA', 'TYR', 'SOD1']",0.9998617840333556,0,0,3
123,Dopaminergic Neurogenesis WP2855,0.2407466337964126,2.0594250795036477,2.9326423410876847,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.9998617840333556,0,0,3
124,ID signaling pathway WP53,0.2407466337964126,2.0594250795036477,2.9326423410876847,"['RBL1', 'ID2', 'ELK1']",0.9998617840333556,0,0,3
125,Fas ligand pathway and stress induction of heat shock proteins WP314,0.2465591682999182,1.4243219597550307,1.9942690646269168,"['DAXX', 'JUN', 'CASP6', 'MAPKAPK2', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.9998617840333556,0,0,8
126,"GPCRs, Other WP117",0.2465591682999182,1.4243219597550307,1.9942690646269168,"['GPR162', 'ADORA2A', 'FSHR', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2']",0.9998617840333556,0,0,8
127,Base Excision Repair WP4752,0.25009132592480776,1.4629189559133857,2.02750198723901,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'APEX1', 'POLD2', 'POLE3']",0.9998617840333556,0,0,7
128,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.2510354223721322,1.7475188566891624,2.415352803355744,"['FGF7', 'SUV39H1', 'CDC37', 'FN1']",0.9998617840333556,0,0,4
129,Complement and Coagulation Cascades WP558,0.25357218937011494,1.602009611183923,2.198128162301043,"['CPB2', 'SERPIND1', 'F12', 'SERPING1', 'CLU']",0.9998617840333556,0,0,5
130,Urea cycle and associated pathways WP4595,0.25357218937011494,1.602009611183923,2.198128162301043,"['OAT', 'GOT1', 'MDH2', 'GOT2', 'NOS1']",0.9998617840333556,0,0,5
131,Endometrial cancer WP4155,0.26973020388726304,1.2820333041191936,1.679890628079778,"['CDKN1A', 'GADD45B', 'PDPK1', 'BAD', 'GADD45A', 'BAX', 'FOS', 'FGF1', 'ELK1', 'HRAS', 'MAPK3', 'GADD45G']",0.9998617840333556,0,0,12
132,miRNA regulation of DNA damage response WP1530,0.26973020388726304,1.2820333041191936,1.679890628079778,"['CDKN1A', 'CDKN1B', 'RRM2B', 'CCNE2', 'GADD45B', 'GADD45A', 'E2F1', 'CYCS', 'BAX', 'BBC3', 'GADD45G', 'RAD9A']",0.9998617840333556,0,0,12
133,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.27614826037084855,1.1881214254289485,1.5288953024481167,"['CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'CEBPB', 'TSPYL1', 'YWHAB', 'SSTR1', 'HSP90B1', 'NEUROD1', 'ADCYAP1', 'AR', 'PRKAR1A', 'BHLHE40', 'PKNOX1', 'SCN3B', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'YWHAH']",0.9998617840333556,0,0,21
134,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.2767491204805294,1.289755670224245,1.65687673544869,"['CACNB3', 'ITGA4', 'LAMA2', 'ITGA10', 'PKP2', 'ITGA8', 'ATP2A2', 'EMD', 'ACTB', 'SGCG', 'ACTG1']",0.9998617840333556,0,0,11
135,ACE Inhibitor Pathway WP554,0.27696298821676096,2.4022687609075044,3.084204153082511,"['MAS1', 'ATP6AP2']",0.9998617840333556,0,0,2
136,Drug Induction of Bile Acid Pathway WP2289,0.27696298821676096,2.4022687609075044,3.084204153082511,"['ABCB1', 'SLC10A1']",0.9998617840333556,0,0,2
137,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.27696298821676096,2.4022687609075044,3.084204153082511,"['E2F1', 'BAX']",0.9998617840333556,0,0,2
138,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.27696298821676096,2.4022687609075044,3.084204153082511,"['AHCY', 'MAT2B']",0.9998617840333556,0,0,2
139,Peroxiredoxin 2 induced ovarian failure WP4873,0.27696298821676096,2.4022687609075044,3.084204153082511,"['STAR', 'BAX']",0.9998617840333556,0,0,2
140,Tamoxifen metabolism WP691,0.27696298821676096,2.4022687609075044,3.084204153082511,"['CYP1B1', 'CYP3A5']",0.9998617840333556,0,0,2
141,Alpha 6 Beta 4 signaling pathway WP244,0.2843901557495972,1.4417832167832167,1.8129100332829302,"['LAMA2', 'LAMA3', 'PRKCD', 'RAC1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,6
142,Development of ureteric collection system WP5053,0.2843901557495972,1.4417832167832167,1.8129100332829302,"['GRIP1', 'FRAS1', 'ITGA8', 'GFRA1', 'SPRY1', 'ETV4']",0.9998617840333556,0,0,6
143,Endothelin Pathways WP2197,0.2843901557495972,1.4417832167832167,1.8129100332829302,"['ADCY10', 'GNA15', 'ATP2A2', 'ADRB1', 'CALM1', 'CALM2']",0.9998617840333556,0,0,6
144,Nuclear receptors WP170,0.2843901557495972,1.4417832167832167,1.8129100332829302,"['NR4A1', 'AR', 'THRA', 'ESRRB', 'PPARG', 'NR2F6']",0.9998617840333556,0,0,6
145,White fat cell differentiation WP4149,0.28931032446822647,1.5017474879860202,1.862550401195042,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.9998617840333556,0,0,5
146,RAS and bradykinin pathways in COVID-19 WP4969,0.2914863171367872,1.8018332605848975,2.2212319591985956,"['F12', 'SERPING1', 'NOS1']",0.9998617840333556,0,0,3
147,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.2914863171367872,1.8018332605848975,2.2212319591985956,"['PTTG1', 'ANAPC11', 'MAD2L1']",0.9998617840333556,0,0,3
148,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.2917496400490586,1.3108812412969961,1.6148211717071943,"['CEBPA', 'CDKN1A', 'CEBPB', 'ICMT', 'E2F1', 'PPARG', 'JUNB', 'EMD', 'ACTB']",0.9998617840333556,0,0,9
149,Methionine De Novo and Salvage Pathway WP3580,0.2925308502815456,1.6017467248908297,1.9688432832096143,"['AHCY', 'AMD1', 'ODC1', 'MAT2B']",0.9998617840333556,0,0,4
150,Urea cycle and metabolism of amino groups WP497,0.2925308502815456,1.6017467248908297,1.9688432832096143,"['OAT', 'ODC1', 'PYCR3', 'CKB']",0.9998617840333556,0,0,4
151,Vitamin D-sensitive calcium signaling in depression WP4698,0.30815157694935924,1.3456405771753388,1.5840389501926306,"['CYP27A1', 'G6PD', 'CHRM1', 'CALB1', 'GPX4', 'KCNQ3', 'ITPR2']",0.9998617840333556,0,0,7
152,COVID-19 adverse outcome pathway WP4891,0.31500848029750883,4.803750545137374,5.549079914574131,['IL7'],0.9998617840333556,0,0,1
153,Gastric acid production WP2596,0.31500848029750883,4.803750545137374,5.549079914574131,['CCK'],0.9998617840333556,0,0,1
154,Nanomaterial-induced inflammasome activation WP3890,0.31500848029750883,4.803750545137374,5.549079914574131,['CTSB'],0.9998617840333556,0,0,1
155,Thyroxine (Thyroid Hormone) Production WP1981,0.31500848029750883,4.803750545137374,5.549079914574131,['TSHR'],0.9998617840333556,0,0,1
156,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.31687514704750014,1.373001998001998,1.5779190321171779,"['NDUFA13', 'HSP90AA1', 'IL18', 'RAC1', 'NLRP1', 'AAMP']",0.9998617840333556,0,0,6
157,16p11.2 proximal deletion syndrome WP4949,0.32426582258296904,1.2016659359929855,1.3533061546156322,"['IGFBP3', 'SEZ6L2', 'PPP2CA', 'CCT6A', 'PPP2R1A', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9998617840333556,0,0,13
158,7-oxo-C and 7beta-HC pathways WP5064,0.3258531959941512,1.4132809086937528,1.5847236386960903,"['HSD11B1', 'CYP27A1', 'HSD11B2', 'DBP', 'ACOT4']",0.9998617840333556,0,0,5
159,DNA Mismatch Repair WP531,0.3258531959941512,1.4132809086937528,1.5847236386960903,"['POLE4', 'POLD4', 'RPA3', 'POLD2', 'POLE3']",0.9998617840333556,0,0,5
160,Physiological and pathological hypertrophy of the heart WP1528,0.3258531959941512,1.4132809086937528,1.5847236386960903,"['JUN', 'RAC1', 'FOS', 'CALM1', 'CALM2']",0.9998617840333556,0,0,5
161,Unfolded protein response WP4925,0.3258531959941512,1.4132809086937528,1.5847236386960903,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.9998617840333556,0,0,5
162,PDGF Pathway WP2526,0.3273019058735971,1.2815398075240594,1.4313162796590728,"['JUN', 'PDGFB', 'ARFIP2', 'RAC1', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,8
163,22q11.2 copy number variation syndrome WP4657,0.3346019732930385,1.1652965120919467,1.2757824612881963,"['RTN4R', 'RANBP1', 'RTL10', 'OAT', 'SERPIND1', 'EMC10', 'RTN4', 'SLC7A4', 'ACTA2', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'DGCR6L', 'RAN', 'FGF10']",0.9998617840333556,0,0,16
164,Constitutive Androstane Receptor Pathway WP2875,0.33480470126913653,1.478401074907625,1.6176781332303887,"['PTPA', 'HSP90AA1', 'ABCB1', 'CYP3A5']",0.9998617840333556,0,0,4
165,Nanomaterial induced apoptosis WP2507,0.33480470126913653,1.478401074907625,1.6176781332303887,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.9998617840333556,0,0,4
166,Purine metabolism and related disorders WP4224,0.33480470126913653,1.478401074907625,1.6176781332303887,"['PRPS1', 'RRM2B', 'PFAS', 'APRT']",0.9998617840333556,0,0,4
167,Triacylglyceride synthesis WP325,0.33480470126913653,1.478401074907625,1.6176781332303887,"['DGAT2', 'MOGAT1', 'LPL', 'AGPAT1']",0.9998617840333556,0,0,4
168,Vitamin B12 metabolism WP1533,0.33480470126913653,1.478401074907625,1.6176781332303887,"['CUBN', 'HBA1', 'SOD2', 'SOD1']",0.9998617840333556,0,0,4
169,Corticotropin-releasing hormone signaling pathway WP2355,0.33495397133962795,1.1805632502308403,1.291255405374983,"['GNAZ', 'HSP90AA1', 'JUND', 'PRKCD', 'IL18', 'FOS', 'ELK1', 'FOSL2', 'NR4A1', 'STAR', 'FOSB', 'PRKCQ', 'JUNB', 'MAPK3']",0.9998617840333556,0,0,14
170,Airway smooth muscle cell contraction WP4962,0.3428182231067157,1.601484068092536,1.71447667095271,"['RYR1', 'CALM1', 'CALM2']",0.9998617840333556,0,0,3
171,Ganglio Sphingolipid Metabolism WP1423,0.3428182231067157,1.601484068092536,1.71447667095271,"['B3GALT1', 'B3GALT4', 'FUT1']",0.9998617840333556,0,0,3
172,miRNAs involved in DNA damage response WP1545,0.3428182231067157,1.601484068092536,1.71447667095271,"['CDKN1A', 'CDKN1B', 'E2F1']",0.9998617840333556,0,0,3
173,Overview of nanoparticle effects WP3287,0.3428182231067157,1.601484068092536,1.71447667095271,"['LAMA3', 'FN1', 'BAX']",0.9998617840333556,0,0,3
174,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3428182231067157,1.601484068092536,1.71447667095271,"['CDH6', 'FN1', 'MAPK3']",0.9998617840333556,0,0,3
175,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3432395731853105,1.2357486714598311,1.3214189395568257,"['PPP1R15A', 'PPP1CC', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R1A', 'DDIT3', 'PPP1R1B']",0.9998617840333556,0,0,9
176,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.3461958882972871,1.9216404886561955,2.038381134103818,"['BATF3', 'ID2']",0.9998617840333556,0,0,2
177,Dual hijack model of Vif in HIV infection WP3300,0.3461958882972871,1.9216404886561955,2.038381134103818,"['UBB', 'ELOB']",0.9998617840333556,0,0,2
178,Inflammatory Response Pathway WP453,0.3461958882972871,1.9216404886561955,2.038381134103818,"['FN1', 'TNFRSF1A']",0.9998617840333556,0,0,2
179,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.3461958882972871,1.9216404886561955,2.038381134103818,"['JUN', 'IRAK1']",0.9998617840333556,0,0,2
180,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3461958882972871,1.9216404886561955,2.038381134103818,"['ELK1', 'MEF2D']",0.9998617840333556,0,0,2
181,Sulfation Biotransformation Reaction WP692,0.3461958882972871,1.9216404886561955,2.038381134103818,"['G6PD', 'SULT4A1']",0.9998617840333556,0,0,2
182,Prion disease pathway WP3995,0.3498758293612434,1.310473617291799,1.3762292004839711,"['PRNP', 'HSPA5', 'RFX5', 'ELK1', 'HSP90B1', 'MAPK3']",0.9998617840333556,0,0,6
183,Osteoblast differentiation WP4787,0.3535712785873623,1.147799195418867,1.1933325929280054,"['FZD1', 'PRKCH', 'JAG1', 'NOTCH4', 'PRKCD', 'WNT7A', 'PIK3C2G', 'FGF1', 'DLL3', 'FGF7', 'HEY1', 'PRKCQ', 'PPARG', 'WNT2', 'FGF10', 'MAPK3']",0.9998617840333556,0,0,16
184,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.35659920657879995,1.176948255200415,1.2136017175769072,"['EGR1', 'JUN', 'CDKN1B', 'PDPK1', 'APEX1', 'RPS6', 'E2F1', 'FOS', 'HRAS', 'TSHR', 'MYL12B', 'MAPK3']",0.9998617840333556,0,0,12
185,Metapathway biotransformation Phase I and II WP702,0.3617734692003702,1.1348265261308739,1.153820161645201,"['GSTM4', 'CHST9', 'GPX4', 'GSTP1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'HS3ST1', 'CYP3A7', 'CYP27A1', 'CYP39A1', 'CYP26B1', 'CYP1B1', 'CHST1', 'NAT8L', 'SULT4A1', 'CHST2']",0.9998617840333556,0,0,17
186,Oxidative Stress WP408,0.36282294034822526,1.3346439493228484,1.3531158638162288,"['NOX5', 'FOS', 'SOD2', 'JUNB', 'SOD1']",0.9998617840333556,0,0,5
187,TNF-alpha signaling pathway WP231,0.3644369843575757,1.1442988779539898,1.155057146778267,"['HSP90AA1', 'JUN', 'BAD', 'TNFRSF1A', 'PPP2CA', 'SMPD2', 'PSMD2', 'RFK', 'CDC37', 'BAX', 'RAC1', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9998617840333556,0,0,15
188,DNA Replication WP466,0.3684243216796883,1.245736773065151,1.2438930290991366,"['POLD4', 'RPA3', 'UBC', 'POLD2', 'MCM3', 'MCM4', 'UBA52']",0.9998617840333556,0,0,7
189,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3684243216796883,1.245736773065151,1.2438930290991366,"['BAD', 'PDE3A', 'NEFL', 'CYCS', 'NOS1', 'CALM1', 'CALM2']",0.9998617840333556,0,0,7
190,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3695049488129101,1.201312910284464,1.1960164963513722,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'NRG1', 'IER3']",0.9998617840333556,0,0,9
191,Apoptosis Modulation by HSP70 WP384,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['CASP6', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.9998617840333556,0,0,4
192,Globo Sphingolipid Metabolism WP1424,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['B3GALNT1', 'FUT2', 'ST6GALNAC3', 'FUT1']",0.9998617840333556,0,0,4
193,Ovarian infertility WP34,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['EGR1', 'CEBPB', 'CDKN1B', 'FSHR']",0.9998617840333556,0,0,4
194,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['MAPKAPK2', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,4
195,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['EGR1', 'MAPKAPK2', 'ELK1', 'MAPK3']",0.9998617840333556,0,0,4
196,TYROBP causal network in microglia WP3945,0.37729412302609733,1.3726762320648784,1.3379890173760594,"['RBM47', 'ADAP2', 'IL18', 'SFT2D2']",0.9998617840333556,0,0,4
197,Melatonin metabolism and effects WP3298,0.383129943573664,1.2533824870781392,1.2024714304230923,"['PER2', 'IRAK1', 'CYP1B1', 'ADRB1', 'CALM1', 'CALM2']",0.9998617840333556,0,0,6
198,Prader-Willi and Angelman Syndrome WP3998,0.38341932250288174,1.2012248468941382,1.1515254323935877,"['MAGEL2', 'CDKN2C', 'CDKN2A', 'E2F1', 'NDN', 'GHRL', 'TYR', 'GABRD']",0.9998617840333556,0,0,8
199,DNA damage response (only ATM dependent) WP710,0.39205128691721985,1.1143260678703668,1.043413269511158,"['JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'WNT7A', 'PIK3C2G', 'SOD2', 'BBC3', 'FRAT1', 'CCNG2', 'RAC3', 'BAX', 'RAC1', 'WNT2', 'HRAS']",0.9998617840333556,0,0,16
200,Biomarkers for pyrimidine metabolism disorders WP4584,0.39380426336315283,1.4412047140986468,1.3430605273535183,"['RRM2', 'RRM2B', 'CKB']",0.9998617840333556,0,0,3
201,BMP Signaling Pathway in Eyelid Development WP3927,0.39380426336315283,1.4412047140986468,1.3430605273535183,"['JUN', 'MAPK3', 'FGF10']",0.9998617840333556,0,0,3
202,Nicotine Activity on Dopaminergic Neurons WP1602,0.39380426336315283,1.4412047140986468,1.3430605273535183,"['CHRNB2', 'PPP1R1B', 'SLC18A2']",0.9998617840333556,0,0,3
203,Tryptophan catabolism leading to NAD+ production WP4210,0.39380426336315283,1.4412047140986468,1.3430605273535183,"['TDO2', 'HAAO', 'KMO']",0.9998617840333556,0,0,3
204,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4130512880166804,1.6012216404886561,1.4157737698492927,"['JAG1', 'WNT2']",0.9998617840333556,0,0,2
205,Blood Clotting Cascade WP272,0.4130512880166804,1.6012216404886561,1.4157737698492927,"['F8A1', 'F12']",0.9998617840333556,0,0,2
206,Farnesoid X receptor pathway WP2879,0.4130512880166804,1.6012216404886561,1.4157737698492927,"['SLC10A1', 'FKBP5']",0.9998617840333556,0,0,2
207,Leptin and adiponectin WP3934,0.4130512880166804,1.6012216404886561,1.4157737698492927,"['LEPR', 'ADIPOR1']",0.9998617840333556,0,0,2
208,IL-7 signaling pathway WP205,0.4194971284068463,1.281048034934498,1.1128446323973646,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.9998617840333556,0,0,4
209,let-7 inhibition of ES cell reprogramming WP3299,0.4330854510015885,2.40165721761884,2.0097553308812155,['EGR1'],0.9998617840333556,0,0,1
210,Macrophage markers WP4146,0.4330854510015885,2.40165721761884,2.0097553308812155,['CD74'],0.9998617840333556,0,0,1
211,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.4330854510015885,2.40165721761884,2.0097553308812155,['FURIN'],0.9998617840333556,0,0,1
212,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.4330854510015885,2.40165721761884,2.0097553308812155,['MAS1'],0.9998617840333556,0,0,1
213,Glycosylation and related congenital defects WP4521,0.4366593490929684,1.200961118392311,0.9951186758124169,"['DPM3', 'MPI', 'DOLK', 'MGAT2', 'MPDU1']",0.9998617840333556,0,0,5
214,Glioblastoma signaling pathways WP2261,0.4385311144005702,1.0848613469156763,0.8942778017329212,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'PDPK1', 'CDKN2A', 'PRKCD', 'PIK3C2G', 'FOXO4', 'E2F1', 'SPRY2', 'PRKCQ', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,14
215,Eukaryotic Transcription Initiation WP405,0.4399167575059314,1.1303587051618547,0.9282163837544104,"['TAF13', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'TAF6', 'POLR2I', 'POLR2K']",0.9998617840333556,0,0,8
216,Eicosanoid Synthesis WP167,0.4436786753583955,1.3100670608309195,1.0646321316325629,"['PTGES2', 'ALOX12', 'PTGES']",0.9998617840333556,0,0,3
217,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4436786753583955,1.3100670608309195,1.0646321316325629,"['EGLN2', 'BCL2L2', 'TNFRSF1A']",0.9998617840333556,0,0,3
218,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4488690773396341,1.108601245581552,0.8880162273953482,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'HRAS', 'PLCB2', 'TNFRSF1A', 'MAPK3']",0.9998617840333556,0,0,9
219,Notch Signaling Pathway Netpath WP61,0.4488690773396341,1.108601245581552,0.8880162273953482,"['PSENEN', 'APH1A', 'CDKN1A', 'JAG1', 'MAML2', 'HEY1', 'NOTCH4', 'SKP1', 'DLL3']",0.9998617840333556,0,0,9
220,IL-5 signaling pathway WP127,0.44942482923180616,1.1529020979020979,0.9220757308932341,"['GSK3A', 'JUN', 'RPS6', 'FOS', 'ELK1', 'MAPK3']",0.9998617840333556,0,0,6
221,Oxidative Damage WP3941,0.44942482923180616,1.1529020979020979,0.9220757308932341,"['CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'CYCS', 'NFKBIE']",0.9998617840333556,0,0,6
222,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.45661849444247044,1.0917847476516478,0.8558577509563753,"['ANGPT2', 'BAD', 'STMN1', 'FN1', 'BAX', 'NOS1', 'RAC1', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9998617840333556,0,0,10
223,Common Pathways Underlying Drug Addiction WP2636,0.45955520497029784,1.1208570179274158,0.8714620755549242,"['PPP1CC', 'PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9998617840333556,0,0,7
224,Modulators of TCR signaling and T cell activation WP5072,0.46794847003461304,1.097962754655668,0.8337897272812638,"['FIBP', 'CDKN1B', 'NDUFB10', 'PDPK1', 'ELOB', 'PRKCQ', 'MEF2D', 'ZFP36L1']",0.9998617840333556,0,0,8
225,Non-small cell lung cancer WP4255,0.46956445244976375,1.0674846625766872,0.8069647220036209,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'E2F1', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'MAPK3', 'GADD45G']",0.9998617840333556,0,0,12
226,Oxysterols derived from cholesterol WP4545,0.47291390387016563,1.1436684765649379,0.856426907526099,"['CYP39A1', 'CYP27A1', 'DBP', 'INSIG1', 'ACOT4']",0.9998617840333556,0,0,5
227,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.47291390387016563,1.1436684765649379,0.856426907526099,"['CDKN1B', 'BAD', 'TFEB', 'FOXO4', 'HRAS']",0.9998617840333556,0,0,5
228,The influence of laminopathies on Wnt signaling WP4844,0.47291390387016563,1.1436684765649379,0.856426907526099,"['CEBPA', 'CEBPB', 'ICMT', 'PPARG', 'EMD']",0.9998617840333556,0,0,5
229,Estrogen Receptor Pathway WP2881,0.47629229806629786,1.3723510346546997,1.017905069807914,"['JUN', 'CYP1B1']",0.9998617840333556,0,0,2
230,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.47629229806629786,1.3723510346546997,1.017905069807914,"['PRKCQ', 'MAFK']",0.9998617840333556,0,0,2
231,Genes targeted by miRNAs in adipocytes WP1992,0.47629229806629786,1.3723510346546997,1.017905069807914,"['TMSB4X', 'KCNJ2']",0.9998617840333556,0,0,2
232,Glutathione metabolism WP100,0.47629229806629786,1.3723510346546997,1.017905069807914,"['G6PD', 'GPX4']",0.9998617840333556,0,0,2
233,miR-509-3p alteration of YAP1/ECM axis WP3967,0.47629229806629786,1.3723510346546997,1.017905069807914,"['SPARC', 'FN1']",0.9998617840333556,0,0,2
234,Neuroinflammation WP4919,0.47629229806629786,1.3723510346546997,1.017905069807914,"['JUN', 'FOS']",0.9998617840333556,0,0,2
235,Purine metabolism WP4792,0.47629229806629786,1.3723510346546997,1.017905069807914,"['PRPS1', 'APRT']",0.9998617840333556,0,0,2
236,Thiamine metabolic pathways WP4297,0.47629229806629786,1.3723510346546997,1.017905069807914,"['BCKDK', 'SLC19A3']",0.9998617840333556,0,0,2
237,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.48121207206933225,1.0325518422038131,0.7552571618581824,"['NSF', 'SHC4', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'PDPK1', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'MARCKS', 'CFL1', 'RAC1', 'HRAS', 'MAPK3', 'CDK5R1']",0.9998617840333556,0,0,23
238,Proteasome Degradation WP183,0.48138513636694996,1.0674255691768826,0.7803816295255265,"['PSMD8', 'PSMB6', 'PSMC5', 'UBB', 'H2AFZ', 'PSMD2', 'PSMD3', 'UBC', 'HLA-C', 'PSMB10']",0.9998617840333556,0,0,10
239,G13 Signaling Pathway WP524,0.48202633530256533,1.1084588488434641,0.808905081923833,"['CFL2', 'CFL1', 'ARHGDIG', 'RAC1', 'CALM1', 'CALM2']",0.9998617840333556,0,0,6
240,Apoptosis WP254,0.48695868021040495,1.0567323696890056,0.760399257001557,"['JUN', 'CRADD', 'CASP6', 'CDKN2A', 'BAD', 'CYCS', 'BAX', 'NFKBIE', 'BCL2L2', 'BBC3', 'TNFRSF1A']",0.9998617840333556,0,0,11
241,Glycosaminoglycan degradation WP4815,0.4918394655988578,1.2007856831078132,0.852081009216274,"['HPSE2', 'IDS', 'SGSH']",0.9998617840333556,0,0,3
242,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.4918394655988578,1.2007856831078132,0.852081009216274,"['JUN', 'PRKCQ', 'MAPK3']",0.9998617840333556,0,0,3
243,Phosphodiesterases in neuronal function WP4222,0.49566154654015016,1.0673665791776028,0.7491439897164356,"['ADCY10', 'PDE10A', 'ADORA2A', 'PPP1R1B', 'PDE3A', 'PDE6C', 'PDE5A', 'NOS1']",0.9998617840333556,0,0,8
244,Synaptic Vesicle Pathway WP2267,0.49566154654015016,1.0673665791776028,0.7491439897164356,"['NSF', 'RAB3A', 'SLC17A7', 'PARK7', 'SYN3', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9998617840333556,0,0,8
245,Pancreatic adenocarcinoma pathway WP4263,0.5007895159159328,1.0345074224021593,0.7154336712902412,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PRKCD', 'PEBP1', 'DUSP6', 'GADD45G', 'E2F1', 'RAC3', 'BAX', 'RAC1', 'MAPK3']",0.9998617840333556,0,0,14
246,Cardiac Progenitor Differentiation WP2406,0.5013708026554589,1.1301310043668122,0.7802529856878473,"['MESP1', 'ACTC1', 'NRG1', 'THY1']",0.9998617840333556,0,0,4
247,Differentiation Pathway WP2848,0.5013708026554589,1.1301310043668122,0.7802529856878473,"['PDGFB', 'FGF1', 'WNT2', 'FGF10']",0.9998617840333556,0,0,4
248,Fatty Acid Biosynthesis WP357,0.5013708026554589,1.1301310043668122,0.7802529856878473,"['ACLY', 'ECHS1', 'ACSL5', 'ACACB']",0.9998617840333556,0,0,4
249,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5083772407289406,1.0915842567218714,0.7384911423642146,"['ACTA2', 'BAX', 'PRKCQ', 'NOS1', 'TNFRSF1A']",0.9998617840333556,0,0,5
250,Ciliary landscape WP4352,0.5132620436985321,1.0079646017699115,0.6722808983475137,"['DOCK5', 'ECHS1', 'ZMYND19', 'SSNA1', 'VPS4A', 'COPS7A', 'PSMD8', 'PGRMC2', 'EXOSC4', 'APMAP', 'ARHGDIA', 'NEFL', 'NEFM', 'TMED1', 'RAC1', 'DCAF11', 'NINL', 'EXOC8', 'NDUFA5', 'RHBDD2', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'LSM4', 'RAB14', 'TTC30A', 'GID8', 'ERF', 'MCM3', 'CD2BP2', 'MCM4', 'CALM1', 'COPS8', 'CALM2']",0.9998617840333556,0,0,34
251,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5140071036224119,1.0673076923076923,0.710312687128269,"['JUN', 'IFI27', 'DDIT3', 'FOS', 'JUNB', 'MAPK3']",0.9998617840333556,0,0,6
252,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5187709942620091,1.05061215566244,0.6895091275745215,"['ACAN', 'THRA', 'TIMP3', 'PTH1R', 'CALM1', 'SLC38A2', 'CALM2']",0.9998617840333556,0,0,7
253,Endochondral Ossification WP474,0.5187709942620091,1.05061215566244,0.6895091275745215,"['ACAN', 'THRA', 'TIMP3', 'PTH1R', 'CALM1', 'SLC38A2', 'CALM2']",0.9998617840333556,0,0,7
254,Codeine and Morphine Metabolism WP1604,0.5308159448017007,1.6009594417793285,1.0139515532542913,['ABCB1'],0.9998617840333556,0,0,1
255,Composition of Lipid Particles WP3601,0.5308159448017007,1.6009594417793285,1.0139515532542913,['LPL'],0.9998617840333556,0,0,1
256,Fatty Acid Omega Oxidation WP206,0.5308159448017007,1.6009594417793285,1.0139515532542913,['ALDH1A1'],0.9998617840333556,0,0,1
257,Platelet-mediated interactions with vascular and circulating cells WP4462,0.5308159448017007,1.6009594417793285,1.0139515532542913,['SELP'],0.9998617840333556,0,0,1
258,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.5308159448017007,1.6009594417793285,1.0139515532542913,['RAC1'],0.9998617840333556,0,0,1
259,Role of Osx and miRNAs in tooth development WP3971,0.5308159448017007,1.6009594417793285,1.0139515532542913,['NOTCH4'],0.9998617840333556,0,0,1
260,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5308159448017007,1.6009594417793285,1.0139515532542913,['CHRM1'],0.9998617840333556,0,0,1
261,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5308159448017007,1.6009594417793285,1.0139515532542913,['DLL3'],0.9998617840333556,0,0,1
262,Sulindac Metabolic Pathway WP2542,0.5308159448017007,1.6009594417793285,1.0139515532542913,['CYP1B1'],0.9998617840333556,0,0,1
263,Vitamin B6-dependent and responsive disorders WP4228,0.5308159448017007,1.6009594417793285,1.0139515532542913,['PNPO'],0.9998617840333556,0,0,1
264,Alanine and aspartate metabolism WP106,0.5351786797214284,1.2006980802792322,0.7506219365717571,"['GOT1', 'GOT2']",0.9998617840333556,0,0,2
265,Cysteine and methionine catabolism WP4504,0.5351786797214284,1.2006980802792322,0.7506219365717571,"['AHCY', 'GOT1']",0.9998617840333556,0,0,2
266,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5351786797214284,1.2006980802792322,0.7506219365717571,"['GABBR1', 'GRM4']",0.9998617840333556,0,0,2
267,Nanoparticle triggered regulated necrosis WP2513,0.5351786797214284,1.2006980802792322,0.7506219365717571,"['TNFRSF1A', 'FTL']",0.9998617840333556,0,0,2
268,Osteoclast Signaling WP12,0.5351786797214284,1.2006980802792322,0.7506219365717571,"['ATP6V1G1', 'PDGFB']",0.9998617840333556,0,0,2
269,Microglia Pathogen Phagocytosis Pathway WP3937,0.537833735244612,1.1083168250344155,0.6873845329658099,"['VAV3', 'RAC3', 'RAC1']",0.9998617840333556,0,0,3
270,One-carbon metabolism WP241,0.537833735244612,1.1083168250344155,0.6873845329658099,"['AHCY', 'GLRX', 'MAT2B']",0.9998617840333556,0,0,3
271,Transcription factor regulation in adipogenesis WP3599,0.537833735244612,1.1083168250344155,0.6873845329658099,"['CEBPA', 'CEBPB', 'PPARG']",0.9998617840333556,0,0,3
272,Wnt signaling pathway and pluripotency WP399,0.5388444172036546,1.0069296149114,0.622613178273632,"['FZD1', 'JUN', 'PRKCH', 'PRKCD', 'ESRRB', 'WNT7A', 'ZBTB33', 'PPP2CA', 'PTPA', 'FRAT1', 'PPP2R1A', 'PRKCQ', 'WNT2']",0.9998617840333556,0,0,13
273,PDGFR-beta pathway WP3972,0.5428340505806628,1.0440290994738541,0.637851271354338,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,5
274,Retinoblastoma gene in cancer WP2446,0.5576957957155281,0.9935023723896159,0.5801473989426348,"['CDKN1A', 'CDKN1B', 'RRM2', 'CCNE2', 'TFDP2', 'H2AFZ', 'SUV39H1', 'RPA3', 'STMN1', 'MCM3', 'E2F1', 'MCM4']",0.9998617840333556,0,0,12
275,Focal Adhesion WP306,0.5637608022274401,0.9838594311063587,0.5638746597591853,"['SHC4', 'LAMA2', 'LAMA4', 'LAMA3', 'PDGFB', 'ELK1', 'ACTB', 'THBS4', 'MYL12B', 'ACTG1', 'PPP1CC', 'PDGFD', 'RAC3', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'JUN', 'ITGA4', 'CAV2', 'PDPK1', 'BAD', 'FN1', 'ITGA10', 'ITGA8']",0.9998617840333556,0,0,25
276,Copper homeostasis WP3286,0.5754749925016706,0.99351941162286,0.5489785945725112,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9998617840333556,0,0,6
277,IL-3 signaling pathway WP286,0.5754749925016706,0.99351941162286,0.5489785945725112,"['JUN', 'YWHAB', 'BAD', 'FOS', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,6
278,IL-6 signaling pathway WP364,0.5754749925016706,0.99351941162286,0.5489785945725112,"['BAD', 'PRKCD', 'RAC1', 'JUNB', 'MAPK3', 'NR2F6']",0.9998617840333556,0,0,6
279,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5777539863543347,1.0109859802344288,0.5546341171476133,"['LPL', 'FOXO4', 'RAC1', 'NDRG1']",0.9998617840333556,0,0,4
280,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5813399279421319,1.0290578038286462,0.558181142199186,"['ANGPT2', 'LTBP1', 'MAPK3']",0.9998617840333556,0,0,3
281,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5893324997184565,1.0671902268760907,0.564292561733241,"['SYTL3', 'EXPH5']",0.9998617840333556,0,0,2
282,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5893324997184565,1.0671902268760907,0.564292561733241,"['CDKN1A', 'ROS1']",0.9998617840333556,0,0,2
283,GDNF/RET signaling axis WP4830,0.5893324997184565,1.0671902268760907,0.564292561733241,"['GFRA1', 'SPRY1']",0.9998617840333556,0,0,2
284,Homologous recombination WP186,0.5893324997184565,1.0671902268760907,0.564292561733241,"['POLD4', 'POLD2']",0.9998617840333556,0,0,2
285,Leptin Insulin Overlap WP3935,0.5893324997184565,1.0671902268760907,0.564292561733241,"['PDPK1', 'LEPR']",0.9998617840333556,0,0,2
286,"NAD metabolism, sirtuins and aging WP3630",0.5893324997184565,1.0671902268760907,0.564292561733241,"['PPARG', 'ROS1']",0.9998617840333556,0,0,2
287,Leptin signaling pathway WP2034,0.5996304301297878,0.960227770477442,0.49110058412630675,"['GSK3A', 'BAD', 'CFL2', 'RPS6', 'LEPR', 'BAX', 'RAC1', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9998617840333556,0,0,11
288,Bladder cancer WP2828,0.6080489238019982,0.9603320227173439,0.47776511741448996,"['CDKN1A', 'CDKN2A', 'DAPK2', 'E2F1', 'HRAS']",0.9998617840333556,0,0,5
289,Neural Crest Cell Migration during Development WP4564,0.6080489238019982,0.9603320227173439,0.47776511741448996,"['ARF1', 'JUN', 'RAC1', 'FOS', 'EPHB3']",0.9998617840333556,0,0,5
290,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.611704700454533,1.2006105538595726,0.5901068448765999,['IRAK1'],0.9998617840333556,0,0,1
291,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.611704700454533,1.2006105538595726,0.5901068448765999,['GSTP1'],0.9998617840333556,0,0,1
292,Cytokines and Inflammatory Response WP530,0.611704700454533,1.2006105538595726,0.5901068448765999,['IL7'],0.9998617840333556,0,0,1
293,LTF danger signal response pathway WP4478,0.611704700454533,1.2006105538595726,0.5901068448765999,['IRAK1'],0.9998617840333556,0,0,1
294,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.611704700454533,1.2006105538595726,0.5901068448765999,['FN1'],0.9998617840333556,0,0,1
295,Metabolism of alpha-linolenic acid WP4586,0.611704700454533,1.2006105538595726,0.5901068448765999,['ALOX12'],0.9998617840333556,0,0,1
296,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.611704700454533,1.2006105538595726,0.5901068448765999,['HEY1'],0.9998617840333556,0,0,1
297,PTF1A related regulatory pathway WP4147,0.611704700454533,1.2006105538595726,0.5901068448765999,['FGF10'],0.9998617840333556,0,0,1
298,SARS-CoV-2 and COVID-19 Pathway WP4846,0.611704700454533,1.2006105538595726,0.5901068448765999,['FURIN'],0.9998617840333556,0,0,1
299,Somatic sex determination WP4814,0.611704700454533,1.2006105538595726,0.5901068448765999,['AMH'],0.9998617840333556,0,0,1
300,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.611704700454533,1.2006105538595726,0.5901068448765999,['MAPK3'],0.9998617840333556,0,0,1
301,The alternative pathway of fetal androgen synthesis WP4524,0.611704700454533,1.2006105538595726,0.5901068448765999,['STAR'],0.9998617840333556,0,0,1
302,Vitamin D Metabolism WP1531,0.611704700454533,1.2006105538595726,0.5901068448765999,['CYP27A1'],0.9998617840333556,0,0,1
303,Lung fibrosis WP3624,0.6133315475653324,0.9603493449781659,0.46946642064736793,"['FGF7', 'CEBPB', 'PDGFB', 'FGF1']",0.9998617840333556,0,0,4
304,Neovascularisation processes WP4331,0.6133315475653324,0.9603493449781659,0.46946642064736793,"['JAG1', 'NOTCH4', 'PDGFB', 'MAPK3']",0.9998617840333556,0,0,4
305,Heart Development WP1591,0.6221490576831107,0.9603666521169795,0.455766553618571,"['HEY1', 'BHLHE40', 'FGF10']",0.9998617840333556,0,0,3
306,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6221490576831107,0.9603666521169795,0.455766553618571,"['B3GALNT1', 'B3GALT1', 'ST6GALNAC3']",0.9998617840333556,0,0,3
307,Monoamine Transport WP727,0.6221490576831107,0.9603666521169795,0.455766553618571,"['TDO2', 'ADORA2A', 'NOS1']",0.9998617840333556,0,0,3
308,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6221490576831107,0.9603666521169795,0.455766553618571,"['PTGES2', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,3
309,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6287134667572748,0.9335373852208133,0.433235715894173,"['EIF4A2', 'PRKCD', 'RPS6', 'PIM1', 'PIM2', 'EIF4B', 'MAPK3']",0.9998617840333556,0,0,7
310,Integrated Cancer Pathway WP1971,0.6327983065619539,0.9292521994134897,0.4252290947363233,"['CDKN1A', 'CDKN1B', 'BAD', 'E2F1', 'BAX', 'BBC3']",0.9998617840333556,0,0,6
311,Interleukin-11 Signaling Pathway WP2332,0.6327983065619539,0.9292521994134897,0.4252290947363233,"['PTPA', 'BGLAP', 'PDPK1', 'RPS6', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,6
312,IL-2 signaling pathway WP49,0.6385535343775831,0.9233121618442719,0.4141514514163985,"['JUN', 'RPS6', 'FOS', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,5
313,Cancer immunotherapy by PD-1 blockade WP4585,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['JUN', 'PDCD1LG2']",0.9998617840333556,0,0,2
314,Cell Differentiation - Index expanded WP2023,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['ID2', 'MEF2D']",0.9998617840333556,0,0,2
315,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['RYR1', 'CCK']",0.9998617840333556,0,0,2
316,NOTCH1 regulation of endothelial cell calcification WP3413,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['JAG1', 'DLL3']",0.9998617840333556,0,0,2
317,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['LDHA', 'SLC2A3']",0.9998617840333556,0,0,2
318,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['FZD1', 'DKK3']",0.9998617840333556,0,0,2
319,Serotonin and anxiety WP3947,0.6386353136048332,0.9603839441535776,0.4306570025778293,"['GABRA1', 'FOS']",0.9998617840333556,0,0,2
320,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6518955703570662,0.9271369824729508,0.39669493330401323,"['FZD1', 'SPARC', 'JAG1', 'NOTCH4', 'EIF5A2', 'FN1', 'WNT7A', 'DLL3', 'CLDN20', 'MMP15', 'ID2', 'PKP2', 'STRAP', 'WNT2', 'HRAS', 'MEF2D', 'MAPK3']",0.9998617840333556,0,0,17
321,IL-4 signaling pathway WP395,0.6538854327632735,0.9082239213415427,0.38583452185897976,"['CEBPA', 'CEBPB', 'BAD', 'FOS', 'ELK1', 'MAPK3', 'SOCS5']",0.9998617840333556,0,0,7
322,G Protein Signaling Pathways WP35,0.656914728844028,0.9175800087680842,0.3855680901082244,"['GNAZ', 'PRKCH', 'PRKCD', 'AKAP5', 'GNG10', 'GNG3', 'GNA15', 'PRKD3', 'PRKAR1A', 'PRKCQ', 'CALM1', 'HRAS', 'CALM2']",0.9998617840333556,0,0,13
323,TGF-beta Receptor Signaling WP560,0.6596819352914959,0.9001311188811189,0.3744522738347018,"['FKBP1A', 'JUN', 'FOS', 'HRAS', 'LTBP1', 'MAPK3']",0.9998617840333556,0,0,6
324,Angiogenesis WP1539,0.6601462613154759,0.9002618943692711,0.373873237537064,"['PDGFB', 'TIMP2', 'TIMP3']",0.9998617840333556,0,0,3
325,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6601462613154759,0.9002618943692711,0.373873237537064,"['H3F3B', 'SUV39H1', 'E2F1']",0.9998617840333556,0,0,3
326,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6601462613154759,0.9002618943692711,0.373873237537064,"['BAD', 'BAX', 'BBC3']",0.9998617840333556,0,0,3
327,EGF/EGFR signaling pathway WP437,0.6628074049617954,0.9286912036379139,0.38194359400822764,"['VAV3', 'NDUFA13', 'JUN', 'JUND', 'CAV2', 'PDPK1', 'LIMK2', 'PRKCD', 'PEBP1', 'NEDD8', 'FOXO4', 'FOS', 'ELK1', 'EPN1', 'CFL1', 'STMN1', 'E2F1', 'SPRY2', 'FOSB', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9998617840333556,0,0,24
328,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6675400285485238,0.889034512887724,0.3593085638174089,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,5
329,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6723410917181841,0.8930395328490915,0.3545273089376278,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'WNT2']",0.9998617840333556,0,0,8
330,MAPK Signaling Pathway WP382,0.6736944842316904,0.9303432199983924,0.3674656237830862,"['PDGFB', 'HSPB1', 'FGF1', 'ELK1', 'FGF7', 'STMN1', 'RAC3', 'RAC1', 'HRAS', 'MAPK3', 'DUSP4', 'HSPA8', 'DAXX', 'JUN', 'DUSP2', 'JUND', 'DUSP3', 'GADD45A', 'DUSP1', 'PRKCD', 'FOS', 'DUSP6', 'MAPK8IP1', 'DUSP7', 'TNFRSF1A', 'NR4A1', 'CACNB3', 'DDIT3', 'MAPKAPK2', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9998617840333556,0,0,32
331,Benzo(a)pyrene metabolism WP696,0.6786529759074633,0.9604012211077192,0.3722950801813993,['CYP1B1'],0.9998617840333556,0,0,1
332,EDA signaling in hair follicle development WP3930,0.6786529759074633,0.9604012211077192,0.3722950801813993,['SOSTDC1'],0.9998617840333556,0,0,1
333,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6786529759074633,0.9604012211077192,0.3722950801813993,['RPS6'],0.9998617840333556,0,0,1
334,Insulin signaling in adipocytes (normal condition) WP3634,0.6786529759074633,0.9604012211077192,0.3722950801813993,['RPS6'],0.9998617840333556,0,0,1
335,LDLRAD4 and what we know about it WP4904,0.6786529759074633,0.9604012211077192,0.3722950801813993,['PMEPA1'],0.9998617840333556,0,0,1
336,miRNA Biogenesis WP2338,0.6786529759074633,0.9604012211077192,0.3722950801813993,['RAN'],0.9998617840333556,0,0,1
337,Nephrogenesis WP5052,0.6786529759074633,0.9604012211077192,0.3722950801813993,['JAG1'],0.9998617840333556,0,0,1
338,Serotonin Transporter Activity WP1455,0.6786529759074633,0.9604012211077192,0.3722950801813993,['NOS1'],0.9998617840333556,0,0,1
339,Vitamin B12 Disorders WP4271,0.6786529759074633,0.9604012211077192,0.3722950801813993,['CUBN'],0.9998617840333556,0,0,1
340,Amino Acid metabolism WP3925,0.6806192212770741,0.8948009235543479,0.34427669159063384,"['ACLY', 'LDHA', 'PKM', 'OAT', 'TDO2', 'GOT1', 'MDH2', 'ALDH1A1', 'ODC1', 'GOT2', 'ADH5']",0.9998617840333556,0,0,11
341,Fatty acid transporters WP5061,0.6831500062782397,0.8729969855624305,0.3326474828778051,"['FABP7', 'ACSL5']",0.9998617840333556,0,0,2
342,"GPCRs, Class B Secretin-like WP334",0.6831500062782397,0.8729969855624305,0.3326474828778051,"['ADGRG2', 'PTH1R']",0.9998617840333556,0,0,2
343,miRNA targets in ECM and membrane receptors WP2911,0.6831500062782397,0.8729969855624305,0.3326474828778051,"['LAMA4', 'FN1']",0.9998617840333556,0,0,2
344,Phytochemical activity on NRF2 transcriptional activation WP3,0.6831500062782397,0.8729969855624305,0.3326474828778051,"['CEBPB', 'KEAP1']",0.9998617840333556,0,0,2
345,Type II diabetes mellitus WP1584,0.6831500062782397,0.8729969855624305,0.3326474828778051,"['SURF1', 'PRKCD']",0.9998617840333556,0,0,2
346,Neural Crest Cell Migration in Cancer WP4565,0.6949565970430821,0.8572052674280721,0.3119420420402611,"['ARF1', 'JUN', 'RAC1', 'FOS', 'EPHB3']",0.9998617840333556,0,0,5
347,Type 2 papillary renal cell carcinoma WP4241,0.6949565970430821,0.8572052674280721,0.3119420420402611,"['CDKN1A', 'EGLN2', 'PDGFB', 'TFEB', 'ELOB']",0.9998617840333556,0,0,5
348,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6952935056214551,0.8472282845918813,0.3079007302969227,"['FSHR', 'RPS6', 'MAPK3']",0.9998617840333556,0,0,3
349,Genes controlling nephrogenesis WP4823,0.6952935056214551,0.8472282845918813,0.3079007302969227,"['PDGFB', 'ITGA8', 'ETV4']",0.9998617840333556,0,0,3
350,Signal Transduction of S1P Receptor WP26,0.6952935056214551,0.8472282845918813,0.3079007302969227,"['SMPD2', 'PLCB2', 'MAPK3']",0.9998617840333556,0,0,3
351,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6952935056214551,0.8472282845918813,0.3079007302969227,"['GSK3A', 'CALM1', 'CALM2']",0.9998617840333556,0,0,3
352,GABA receptor Signaling WP4159,0.708241884537339,0.834858553256123,0.2880008201790036,"['GABRA1', 'GABBR1', 'GABRD', 'AP2M1']",0.9998617840333556,0,0,4
353,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7089009811025887,0.8638424507658643,0.29719585758433864,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'HNRNPK', 'CSNK2B', 'WNT7A', 'WNT2']",0.9998617840333556,0,0,9
354,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7096232634305641,0.847027972027972,0.29054843676116027,"['JUN', 'PRKCQ', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.9998617840333556,0,0,6
355,TGF-beta Signaling Pathway WP366,0.7134551458155519,0.8865020717572702,0.29931475557300985,"['KLF10', 'JUN', 'CDKN1A', 'JUND', 'CITED1', 'LIMK2', 'FN1', 'NEDD9', 'FOS', 'KLF6', 'RBL1', 'PARD6A', 'STRAP', 'FOSB', 'RAC1', 'JUNB', 'SKP1']",0.9998617840333556,0,0,17
356,ATM Signaling Pathway WP2516,0.7207760880996782,0.8275711423449481,0.2709689273394138,"['CDKN1A', 'JUN', 'CRADD', 'GADD45A', 'RAD9A']",0.9998617840333556,0,0,5
357,Phosphoinositides metabolism WP4971,0.7207760880996782,0.8275711423449481,0.2709689273394138,"['PIP4P1', 'PIK3C2G', 'PIP4K2C', 'PLCH2', 'PLCB2']",0.9998617840333556,0,0,5
358,Cardiac Hypertrophic Response WP2795,0.7229633521092066,0.839877568867512,0.27245355101204366,"['PDPK1', 'NRG1', 'RAC1', 'CALM1', 'CALM2', 'TNFRSF1A', 'MAPK3']",0.9998617840333556,0,0,7
359,Kit receptor signaling pathway WP304,0.7229633521092066,0.839877568867512,0.27245355101204366,"['BAD', 'RPS6', 'MITF', 'FOS', 'JUNB', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,7
360,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7230618491135209,0.800174520069808,0.2594650022666128,"['ALOX12', 'LTB4R']",0.9998617840333556,0,0,2
361,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7230618491135209,0.800174520069808,0.2594650022666128,"['FRAT1', 'GADD45G']",0.9998617840333556,0,0,2
362,Pyrimidine metabolism and related diseases WP4225,0.7230618491135209,0.800174520069808,0.2594650022666128,"['RRM2', 'RRM2B']",0.9998617840333556,0,0,2
363,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7276139199874148,0.8000872981230903,0.2544155203856577,"['EI24', 'BAX', 'BBC3']",0.9998617840333556,0,0,3
364,Type II interferon signaling (IFNG) WP619,0.7276139199874148,0.8000872981230903,0.2544155203856577,"['PRKCD', 'TAP1', 'IFIT2']",0.9998617840333556,0,0,3
365,ATM Signaling Network in Development and Disease  WP3878,0.7326263986345672,0.8227522477522478,0.25597418164970853,"['PTPA', 'G6PD', 'KAT5', 'ATMIN', 'HSPB1', 'CDK5R1']",0.9998617840333556,0,0,6
366,PPAR signaling pathway WP3942,0.7326263986345672,0.8227522477522478,0.25597418164970853,"['CYP27A1', 'PDPK1', 'FABP7', 'ACSL5', 'LPL', 'PPARG']",0.9998617840333556,0,0,6
367,Cell Differentiation - Index WP2029,0.7340624224228472,0.8002616659398168,0.24740986480720464,['MEF2D'],0.9998617840333556,0,0,1
368,"Cerebral organic acidurias, including diseases WP4519",0.7340624224228472,0.8002616659398168,0.24740986480720464,['MDH2'],0.9998617840333556,0,0,1
369,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7340624224228472,0.8002616659398168,0.24740986480720464,['DHCR24'],0.9998617840333556,0,0,1
370,Estrogen metabolism WP697,0.7340624224228472,0.8002616659398168,0.24740986480720464,['CYP1B1'],0.9998617840333556,0,0,1
371,Liver X receptor pathway WP2874,0.7340624224228472,0.8002616659398168,0.24740986480720464,['ABCG8'],0.9998617840333556,0,0,1
372,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.7340624224228472,0.8002616659398168,0.24740986480720464,['LPL'],0.9998617840333556,0,0,1
373,Methylation Pathways WP704,0.7340624224228472,0.8002616659398168,0.24740986480720464,['MAT2B'],0.9998617840333556,0,0,1
374,Pentose Phosphate Metabolism WP134,0.7340624224228472,0.8002616659398168,0.24740986480720464,['G6PD'],0.9998617840333556,0,0,1
375,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7449929104125026,0.799912625600699,0.2354787401720785,"['CDKN1A', 'JUN', 'RRM2', 'RAC1', 'MAPK3']",0.9998617840333556,0,0,5
376,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7543070349001415,0.7998251748251748,0.22551533564687679,"['FKBP1A', 'JUN', 'FOS', 'HRAS', 'LTBP1', 'MAPK3']",0.9998617840333556,0,0,6
377,Estrogen signaling pathway WP712,0.7571779710944072,0.7579085207562775,0.21081752452518232,"['JUN', 'FOS', 'ELK1']",0.9998617840333556,0,0,3
378,ERK Pathway in Huntington's Disease WP3853,0.7586344763932013,0.7385555108068197,0.20401503172472152,"['ELK1', 'HRAS']",0.9998617840333556,0,0,2
379,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7586344763932013,0.7385555108068197,0.20401503172472152,"['ABCB1', 'PPARG']",0.9998617840333556,0,0,2
380,miRNA regulation of prostate cancer signaling pathways WP3981,0.7613624518608103,0.7679301310043668,0.20937288717060198,"['AR', 'CDKN1A', 'CDKN1B', 'BAD']",0.9998617840333556,0,0,4
381,Prolactin Signaling Pathway WP2037,0.7640361652007701,0.8147227612402461,0.21927460966030216,"['JUN', 'RPS6', 'RAC1', 'FOS', 'ELK1', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.9998617840333556,0,0,9
382,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7746735346973643,0.7781374031374031,0.1986690491845343,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'EMD', 'MAPK3']",0.9998617840333556,0,0,6
383,ATR Signaling WP3875,0.7799210870974318,0.6858762693913152,0.17048314408214327,['RAD9A'],0.9998617840333556,0,0,1
384,Biomarkers for urea cycle disorders WP4583,0.7799210870974318,0.6858762693913152,0.17048314408214327,['GOT1'],0.9998617840333556,0,0,1
385,Canonical NF-KB pathway WP4562,0.7799210870974318,0.6858762693913152,0.17048314408214327,['NFKBIE'],0.9998617840333556,0,0,1
386,"Degradation pathway of sphingolipids, including diseases WP4153",0.7799210870974318,0.6858762693913152,0.17048314408214327,['NEU1'],0.9998617840333556,0,0,1
387,Heme Biosynthesis WP561,0.7799210870974318,0.6858762693913152,0.17048314408214327,['UROD'],0.9998617840333556,0,0,1
388,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7799210870974318,0.6858762693913152,0.17048314408214327,['ELOB'],0.9998617840333556,0,0,1
389,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7799210870974318,0.6858762693913152,0.17048314408214327,['IRAK1'],0.9998617840333556,0,0,1
390,Iron metabolism in placenta WP2007,0.7799210870974318,0.6858762693913152,0.17048314408214327,['FTH1'],0.9998617840333556,0,0,1
391,Mitochondrial CII Assembly WP4920,0.7799210870974318,0.6858762693913152,0.17048314408214327,['SDHAF1'],0.9998617840333556,0,0,1
392,16p11.2 distal deletion syndrome WP4950,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['PLN', 'CD81', 'TUFM']",0.9998617840333556,0,0,3
393,Cannabinoid receptor signaling WP3869,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['ADORA2A', 'PRKAR1A', 'MAPK3']",0.9998617840333556,0,0,3
394,Ethanol effects on histone modifications WP3996,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['ALDH1A3', 'AHCY', 'ALDH1A1']",0.9998617840333556,0,0,3
395,Hematopoietic Stem Cell Differentiation WP2849,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['PIM1', 'FOSB', 'FOS']",0.9998617840333556,0,0,3
396,Signal transduction through IL1R WP4496,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['JUN', 'IRAK1', 'TOLLIP']",0.9998617840333556,0,0,3
397,Wnt signaling in kidney disease WP4150,0.7840915306271259,0.7199476211261457,0.17511251229392227,"['FZD1', 'WNT7A', 'WNT2']",0.9998617840333556,0,0,3
398,Fatty acid beta-oxidation WP143,0.7849491162457405,0.7383271750083977,0.17877587190014563,"['ECHS1', 'TPI1', 'LPL', 'ACSL5']",0.9998617840333556,0,0,4
399,MAPK Cascade WP422,0.7849491162457405,0.7383271750083977,0.17877587190014563,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,4
400,Regulation of Actin Cytoskeleton WP51,0.7887938009883451,0.8379289163410514,0.19879891569934866,"['CHRM1', 'CHRM5', 'PDGFB', 'FN1', 'BRK1', 'PIK3C2G', 'FGF1', 'ACTB', 'ACTG1', 'FGF7', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'PIP4K2C', 'RAC1', 'FGF10', 'MAPK3']",0.9998617840333556,0,0,18
401,AMP-activated protein kinase (AMPK) signaling WP1403,0.7892736632219306,0.7832592354527113,0.18535216521599335,"['GYS2', 'GYS1', 'CCNA1', 'CDKN1A', 'LEPR', 'ADIPOR1', 'EEF2', 'ACACB']",0.9998617840333556,0,0,8
402,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7901773912619509,0.6857392171528297,0.16149008580886406,"['PRXL2B', 'PTGES']",0.9998617840333556,0,0,2
403,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7901773912619509,0.6857392171528297,0.16149008580886406,"['PDGFB', 'OLIG1']",0.9998617840333556,0,0,2
404,Proteoglycan biosynthesis WP4784,0.7901773912619509,0.6857392171528297,0.16149008580886406,"['B3GALT6', 'B4GALT7']",0.9998617840333556,0,0,2
405,Statin inhibition of cholesterol production WP430,0.7901773912619509,0.6857392171528297,0.16149008580886406,"['ABCG8', 'LPL']",0.9998617840333556,0,0,2
406,Nucleotide Excision Repair WP4753,0.7937453150048082,0.7575910931174089,0.1749979599340872,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLD2', 'POLE3']",0.9998617840333556,0,0,6
407,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7937453150048082,0.7575910931174089,0.1749979599340872,"['IRAK1', 'TOLLIP', 'MAPKAPK2', 'FOS', 'ELK1', 'MAPK3']",0.9998617840333556,0,0,6
408,Ebola Virus Pathway on Host WP4217,0.7980774503563806,0.8096642506988846,0.18261947270169873,"['VPS18', 'ITGA4', 'CAV2', 'VPS4A', 'HLA-C', 'ACTB', 'ACTG1', 'RHOB', 'C1QBP', 'TYRO3', 'RAC1', 'CTSB', 'MAPK3']",0.9998617840333556,0,0,13
409,AGE/RAGE pathway WP2324,0.7994193875784462,0.7632468100329928,0.17086774305522048,"['JUN', 'PRKCD', 'CYCS', 'RAC1', 'FOXO4', 'MAPK3', 'SOD1']",0.9998617840333556,0,0,7
410,Male infertility WP4673,0.8037631390223647,0.7992988606485539,0.1746073607790267,"['AR', 'CCNA1', 'CYP26B1', 'SPATA17', 'ABCB1', 'MSH4', 'HMGA1', 'NOS1', 'TEX15', 'SOD2', 'CLU', 'ETV5']",0.9998617840333556,0,0,12
411,Sphingolipid pathway WP1422,0.808485775049364,0.6856020452703124,0.14575364326799392,"['PPP2CA', 'CERS4', 'SERINC1']",0.9998617840333556,0,0,3
412,3q29 copy number variation syndrome WP4906,0.815777431207412,0.7462177525142107,0.15194017035240281,"['JUN', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'DYNLL1', 'DYNLL2']",0.9998617840333556,0,0,7
413,Pathways Regulating Hippo Signaling WP4540,0.8172936701891832,0.7735438675781029,0.15606773481953795,"['CDH6', 'PRKCH', 'PRKD3', 'PRKAR1A', 'FLT3', 'PRKCD', 'PRKCQ', 'RAC1', 'PLCB2', 'CDH7']",0.9998617840333556,0,0,10
414,Biotin Metabolism (including IEMs) WP5031,0.8178746164253852,0.6000872219799389,0.1206452765196369,['ACACB'],0.9998617840333556,0,0,1
415,Cancer immunotherapy by CTLA4 blockade WP4582,0.8178746164253852,0.6000872219799389,0.1206452765196369,['PPP2CA'],0.9998617840333556,0,0,1
416,Serotonin and anxiety-related events WP3944,0.8178746164253852,0.6000872219799389,0.1206452765196369,['FOS'],0.9998617840333556,0,0,1
417,Ebstein-Barr virus LMP1 signaling WP262,0.8180223375251351,0.6399650959860383,0.1285469955522095,"['HSP90AA1', 'IRAK1']",0.9998617840333556,0,0,2
418,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8180223375251351,0.6399650959860383,0.1285469955522095,"['HRAS', 'MAPK3']",0.9998617840333556,0,0,2
419,Head and Neck Squamous Cell Carcinoma WP4674,0.8204795119488448,0.752405949256343,0.14887581059578386,"['FKBP1A', 'CDKN1A', 'PDPK1', 'CDKN2A', 'RPS6', 'E2F1', 'KEAP1', 'HRAS']",0.9998617840333556,0,0,8
420,Regulation of toll-like receptor signaling pathway WP1449,0.8231351506602184,0.7757336837494525,0.15098482833955795,"['JUN', 'CUEDC2', 'FBXW5', 'IRAK1', 'TOLLIP', 'PELI3', 'PELI2', 'RAC1', 'FOS', 'TMED7', 'MAPK3']",0.9998617840333556,0,0,11
421,Regulation of Microtubule Cytoskeleton WP2038,0.8263097489790237,0.7055482743556138,0.1346084346184138,"['PARD6A', 'CFL2', 'STMN1', 'MAPKAPK2', 'RAC1']",0.9998617840333556,0,0,5
422,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.826508325951146,0.6854647535870243,0.13061207890370838,"['MAP1LC3A', 'IGFBP5', 'TNFSF9', 'TNFRSF1A']",0.9998617840333556,0,0,4
423,B Cell Receptor Signaling Pathway WP23,0.8304359667109111,0.7611958969226921,0.14143358877240453,"['JUN', 'GSK3A', 'CD81', 'PDPK1', 'PRKCD', 'RAC1', 'ELK1', 'ILF2', 'HRAS', 'MEF2D']",0.9998617840333556,0,0,10
424,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8304359667109111,0.7611958969226921,0.14143358877240453,"['SHC4', 'PDPK1', 'BAD', 'PDGFD', 'RPS6', 'PDGFB', 'BAX', 'NRG1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,10
425,IL17 signaling pathway WP2112,0.8305087912360993,0.6543787944922821,0.12152911247763842,"['CEBPB', 'IL17RE', 'MAPK3']",0.9998617840333556,0,0,3
426,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8386613966017755,0.7441484946804497,0.1309316132575885,"['CREB3', 'THRA', 'BAD', 'RPS6', 'ITPR2', 'PRKCQ', 'PPARG', 'HRAS', 'TSHR']",0.9998617840333556,0,0,9
427,Immune response to tuberculosis WP4197,0.8425064481589233,0.599912739965096,0.10280942381227877,"['TAP1', 'IFIT1']",0.9998617840333556,0,0,2
428,NAD+ biosynthetic pathways WP3645,0.8425064481589233,0.599912739965096,0.10280942381227877,"['TDO2', 'ACMSD']",0.9998617840333556,0,0,2
429,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8425064481589233,0.599912739965096,0.10280942381227877,"['MDH2', 'IDH3B']",0.9998617840333556,0,0,2
430,Toll-like Receptor Signaling related to MyD88 WP3858,0.8425064481589233,0.599912739965096,0.10280942381227877,"['IRAK1', 'TOLLIP']",0.9998617840333556,0,0,2
431,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8446533584413671,0.6617678060533052,0.11172557210364856,"['ACTA2', 'ACTC1', 'ACTB', 'ACTG1']",0.9998617840333556,0,0,4
432,Notch Signaling WP268,0.8446533584413671,0.6617678060533052,0.11172557210364856,"['APH1A', 'JAG1', 'NOTCH4', 'DLL3']",0.9998617840333556,0,0,4
433,Neural Crest Differentiation WP2064,0.8453578737216326,0.7143335597130869,0.12000462500798734,"['CDH6', 'NOTCH4', 'MITF', 'OLIG1', 'CDH7', 'RHOB', 'DLL3']",0.9998617840333556,0,0,7
434,Hedgehog Signaling Pathway Netpath WP47,0.8492852068000886,0.5333624073266463,0.08713019831079935,['SAP18'],0.9998617840333556,0,0,1
435,Osteopontin Signaling WP1434,0.8492852068000886,0.5333624073266463,0.08713019831079935,['MAPK3'],0.9998617840333556,0,0,1
436,TCA cycle in senescence WP5050,0.8492852068000886,0.5333624073266463,0.08713019831079935,['GOT1'],0.9998617840333556,0,0,1
437,IL-1 signaling pathway WP195,0.8577684797251119,0.6851898101898102,0.10512254222323855,"['JUN', 'IRAK1', 'TOLLIP', 'MAPKAPK2', 'PELI2', 'MAPK3']",0.9998617840333556,0,0,6
438,Cytosolic DNA-sensing pathway WP4655,0.8583059684646551,0.6662297946701616,0.10179633927613711,"['IL18', 'POLR2E', 'POLR3H', 'POLR2K', 'POLR2L']",0.9998617840333556,0,0,5
439,MET in type 1 papillary renal cell carcinoma WP4205,0.8586499014340587,0.6993878443375601,0.10658251488752674,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'RAC1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,7
440,Hepatitis B infection WP4666,0.8592202457520761,0.7745231063931679,0.11751838474726228,"['JUN', 'EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'BAD', 'FOS', 'ELK1', 'CREB3', 'IRAK1', 'CYCS', 'BAX', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,16
441,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8639605383246994,0.5645724258289704,0.08255640082313677,"['FZD1', 'FGF1']",0.9998617840333556,0,0,2
442,Trans-sulfuration and one-carbon metabolism WP2525,0.8639605383246994,0.5645724258289704,0.08255640082313677,"['AHCY', 'MAT2B']",0.9998617840333556,0,0,2
443,Wnt signaling WP428,0.8655109184992033,0.7263970705301703,0.10491737095247351,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'RAC1', 'WNT2', 'PLCB2']",0.9998617840333556,0,0,10
444,Intraflagellar transport proteins binding to dynein WP4532,0.868078289531582,0.5997381056307289,0.08484697276594381,"['DYNLT3', 'DYNLL1', 'DYNLL2']",0.9998617840333556,0,0,3
445,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8709320765482762,0.6691941779151082,0.09247680568105958,"['KAT5', 'CDKN2A', 'ACTL6A', 'E2F1', 'BAX', 'RAD9A']",0.9998617840333556,0,0,6
446,GPR40 Pathway WP3958,0.8752804085231202,0.4799825556040122,0.06393894521312615,['PLCB2'],0.9998617840333556,0,0,1
447,Mammalian disorder of sexual development WP4842,0.8752804085231202,0.4799825556040122,0.06393894521312615,['AMH'],0.9998617840333556,0,0,1
448,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8752804085231202,0.4799825556040122,0.06393894521312615,['SOX4'],0.9998617840333556,0,0,1
449,NO metabolism in cystic fibrosis WP4947,0.8752804085231202,0.4799825556040122,0.06393894521312615,['NOS1'],0.9998617840333556,0,0,1
450,Netrin-UNC5B signaling pathway WP4747,0.8761608903579994,0.6189604169601353,0.08182999623576696,"['PTPA', 'JUN', 'RAC1', 'MAPK3']",0.9998617840333556,0,0,4
451,1q21.1 copy number variation syndrome WP4905,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['PYGO2', 'ACP6']",0.9998617840333556,0,0,2
452,EPO Receptor Signaling WP581,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['EPOR', 'MAPK3']",0.9998617840333556,0,0,2
453,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['CEBPA', 'CEBPB']",0.9998617840333556,0,0,2
454,NRF2-ARE regulation WP4357,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['CEBPB', 'KEAP1']",0.9998617840333556,0,0,2
455,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['GNA15', 'PLCB2']",0.9998617840333556,0,0,2
456,SARS-CoV-2 mitochondrial interactions WP5038,0.8827012702630211,0.5331588132635253,0.06652139761061412,"['PHB', 'PHB2']",0.9998617840333556,0,0,2
457,T-cell receptor (TCR) signaling pathway WP69,0.8828283454609848,0.6849143857017873,0.0853571104825913,"['VAV3', 'JUN', 'PDPK1', 'PRKCD', 'PRKCQ', 'FOS', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,8
458,Autophagy WP4923,0.883950465312187,0.5756962025316456,0.07101457480476975,"['MAP1LC3B', 'ATG101', 'ATG9A']",0.9998617840333556,0,0,3
459,Tumor suppressor activity of SMARCB1 WP4204,0.883950465312187,0.5756962025316456,0.07101457480476975,"['H3F3B', 'CDKN2A', 'ACTL6A']",0.9998617840333556,0,0,3
460,ESC Pluripotency Pathways WP3931,0.8959731929216387,0.7028821725799387,0.07720794117588904,"['FZD1', 'FGF7', 'JUN', 'PDGFB', 'WNT7A', 'FOS', 'FGF1', 'ELK1', 'WNT2', 'HRAS', 'FGF10']",0.9998617840333556,0,0,11
461,Insulin Signaling WP481,0.8968060617444918,0.7601457469531349,0.08279176655997651,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'PDPK1', 'PRKCD', 'PIK3C2G', 'FOS', 'ELK1', 'EHD1', 'GYS2', 'GYS1', 'PFKL', 'PRKCQ', 'RAC1', 'HRAS', 'ARF6', 'MAPK3']",0.9998617840333556,0,0,20
462,RANKL/RANK signaling pathway WP2018,0.8969399141797165,0.6148133212353396,0.0668710343733942,"['JUN', 'MITF', 'RAC1', 'FOS', 'MAPK3']",0.9998617840333556,0,0,5
463,Glycerolipids and Glycerophospholipids WP4722,0.8990262053504168,0.5050518967576008,0.05375928727451204,"['DGAT2', 'CDIPT']",0.9998617840333556,0,0,2
464,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8990262053504168,0.5050518967576008,0.05375928727451204,"['FZD1', 'PLOD2']",0.9998617840333556,0,0,2
465,Integrin-mediated Cell Adhesion WP185,0.9029566233345391,0.6846384788591443,0.06988841822805053,"['VAV3', 'CAPNS1', 'ITGA4', 'CAV2', 'PDPK1', 'ITGA10', 'ITGA8', 'RAC3', 'RAC1', 'HRAS']",0.9998617840333556,0,0,10
466,Gastric Cancer Network 2 WP2363,0.913210980035687,0.47975567190226875,0.043556221396593445,"['S100A6', 'CACYBP']",0.9998617840333556,0,0,2
467,IL-9 signaling pathway WP22,0.9145970904546498,0.39991277802006103,0.0357008731439928,['MAPK3'],0.9998617840333556,0,0,1
468,ErbB signaling pathway WP673,0.9181432831546283,0.6654991243432574,0.05683483554444747,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'PDPK1', 'BAD', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,10
469,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9187300519582323,0.6390201224846894,0.05416522484100328,"['FZD1', 'PDPK1', 'NRG1', 'RAC1', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9998617840333556,0,0,8
470,Target Of Rapamycin (TOR) Signaling WP1471,0.9218129356834583,0.5138741659911454,0.04183601986264545,"['FKBP1A', 'RRAGA', 'RAC1']",0.9998617840333556,0,0,3
471,p53 transcriptional gene network WP4963,0.9260912728296303,0.5707420582912064,0.04382299205863077,"['CDKN1A', 'RRM2B', 'GADD45A', 'BAX', 'BBC3']",0.9998617840333556,0,0,5
472,Riboflavin and CoQ disorders WP5037,0.9293305045300163,0.3691167097185414,0.02705287359536538,['RFK'],0.9998617840333556,0,0,1
473,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9293305045300163,0.3691167097185414,0.02705287359536538,['NFKBIE'],0.9998617840333556,0,0,1
474,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9316719945177724,0.4961092129622661,0.035111863361827596,"['JUN', 'RAC1', 'MAPK3']",0.9998617840333556,0,0,3
475,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9317941420228212,0.5327510917030568,0.03763533054535421,"['MAP1LC3A', 'ATG101', 'GTPBP2', 'FTL']",0.9998617840333556,0,0,4
476,Fluoropyrimidine Activity WP1601,0.9361463609598746,0.4360621926066952,0.0287728862178502,"['RRM2', 'UCK1']",0.9998617840333556,0,0,2
477,Toll-like Receptor Signaling Pathway WP75,0.9372712067570538,0.5751398601398602,0.037259053805385786,"['JUN', 'IRAK1', 'TOLLIP', 'RAC1', 'FOS', 'MAPK3']",0.9998617840333556,0,0,6
478,Allograft Rejection WP2328,0.940373819875211,0.47952859013531207,0.029480363743474902,"['ABCB1', 'HLA-C', 'MICA']",0.9998617840333556,0,0,3
479,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.940373819875211,0.47952859013531207,0.029480363743474902,"['GABRA1', 'SLC12A5', 'GABRD']",0.9998617840333556,0,0,3
480,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9415230133867559,0.3427200797458102,0.020651108325481796,['MAPK3'],0.9998617840333556,0,0,1
481,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9415230133867559,0.3427200797458102,0.020651108325481796,['ACLY'],0.9998617840333556,0,0,1
482,Hippo-Merlin Signaling Dysregulation WP4541,0.9433746430413815,0.6159049703032198,0.03590220119446369,"['CDH6', 'PPP1CC', 'ITGA4', 'PRKAR1A', 'FLT3', 'ITGA10', 'ITGA8', 'HRAS', 'CDH7']",0.9998617840333556,0,0,9
483,Resistin as a regulator of inflammation WP4481,0.9453321900086611,0.4170650276955763,0.023446932681194504,"['PLCB2', 'MAPK3']",0.9998617840333556,0,0,2
484,Nephrotic syndrome WP4758,0.9480386395722628,0.46401768491009704,0.02475999225821605,"['CUBN', 'MYO1E', 'ARHGDIA']",0.9998617840333556,0,0,3
485,Kallmann's Syndrome WP5074,0.9516126586345142,0.3198430004361099,0.01586331667513122,['PRKCQ'],0.9998617840333556,0,0,1
486,Lipid Metabolism Pathway WP3965,0.9532499331773981,0.39965095986038396,0.01913454874141221,"['ACLY', 'PRKAR1A']",0.9998617840333556,0,0,2
487,Nanoparticle-mediated activation of receptor signaling WP2643,0.9532499331773981,0.39965095986038396,0.01913454874141221,"['FN1', 'HRAS']",0.9998617840333556,0,0,2
488,Hippo-Yap signaling pathway WP4537,0.9599619926539467,0.2998255560401221,0.012251347829922106,['NDRG1'],0.9998617840333556,0,0,1
489,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9599619926539467,0.2998255560401221,0.012251347829922106,['FLT3'],0.9998617840333556,0,0,1
490,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9600636199244739,0.383630017452007,0.015635119861842746,"['JUN', 'FOS']",0.9998617840333556,0,0,2
491,mRNA Processing WP411,0.9616595065582226,0.6466207321845759,0.025279530351126903,"['SF3B5', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNU13', 'HNRNPAB', 'HNRNPK', 'SNRPD1', 'CSTF1', 'CD2BP2', 'SRSF3', 'SNRPE', 'HNRNPH2', 'HNRNPA1', 'SRSF9']",0.9998617840333556,0,0,15
492,Wnt Signaling Pathway WP363,0.9637631584637023,0.4675684311428267,0.017257810896246357,"['GSK3A', 'FRAT1', 'PPARG', 'RAC1']",0.9998617840333556,0,0,4
493,One-carbon metabolism and related pathways WP3940,0.9658712847436554,0.42295940637276297,0.014687138183192259,"['GPX4', 'SOD2', 'SOD1']",0.9998617840333556,0,0,3
494,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9659184343491154,0.3688414552288898,0.012789903820637336,"['HEXIM1', 'SUPT4H1']",0.9998617840333556,0,0,2
495,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9668710830809687,0.2821631051024858,0.009506105703231906,['MAP1LC3A'],0.9998617840333556,0,0,1
496,miRNAs involvement in the immune response in sepsis WP4329,0.9668710830809687,0.2821631051024858,0.009506105703231906,['IRAK1'],0.9998617840333556,0,0,1
497,Vitamin D in inflammatory diseases WP4482,0.9668710830809687,0.2821631051024858,0.009506105703231906,['DUSP1'],0.9998617840333556,0,0,1
498,Ras signaling WP4223,0.9674410800588408,0.6504945103205972,0.021531859477816814,"['SHC4', 'FLT3', 'BAD', 'RASAL1', 'FOXO4', 'ELK1', 'ETS2', 'GNG10', 'GNG3', 'RAC3', 'CALM3', 'RAC1', 'CALM1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9998617840333556,0,0,17
499,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9709423352844565,0.3551483420593368,0.010472685124026706,"['RPS6', 'MAPK3']",0.9998617840333556,0,0,2
500,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9725882782918664,0.2664631487134758,0.0074061921381813655,['FLT3'],0.9998617840333556,0,0,1
501,TLR4 Signaling and Tolerance WP3851,0.9725882782918664,0.2664631487134758,0.0074061921381813655,['IRAK1'],0.9998617840333556,0,0,1
502,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.974528129481356,0.4954485170002411,0.012783510563093022,"['ACLY', 'GSK3A', 'RBP4', 'INSIG1', 'LPL', 'PPARG']",0.9998617840333556,0,0,6
503,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9773191180359198,0.2524158193127826,0.005790936280119012,['IRAK1'],0.9998617840333556,0,0,1
504,Histone Modifications WP2369,0.9778113981944135,0.38855922705769935,0.008718675307991882,"['SET', 'H3F3B', 'SUV39H1']",0.9998617840333556,0,0,3
505,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9812337102368526,0.23977322285215874,0.004542410448535669,['HRAS'],0.9998617840333556,0,0,1
506,Sphingolipid Metabolism (general overview) WP4725,0.9812337102368526,0.23977322285215874,0.004542410448535669,['CERS4'],0.9998617840333556,0,0,1
507,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9813094477357189,0.41655591418264665,0.007859338735861695,"['MYO1E', 'CDKN1A', 'CDKN1B', 'JAG1']",0.9998617840333556,0,0,4
508,Mesodermal commitment pathway WP2857,0.9819045973771773,0.5437032319694316,0.009928633603060972,"['VAV3', 'PPP2CA', 'ARL4A', 'PRKAR1A', 'TRIM5', 'C1QBP', 'BHLHE40', 'SLC2A12', 'RPL38', 'AMH']",0.9998617840333556,0,0,10
509,Disruption of postsynaptic signaling by CNV WP4875,0.9820834737369287,0.3195462478184991,0.005777067166882213,"['YWHAG', 'MAPK3']",0.9998617840333556,0,0,2
510,DNA Repair Pathways Full Network WP4946,0.9836705845495094,0.5626643295354952,0.009263823555929916,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'CENPX', 'CETN2', 'RPA3', 'APEX1', 'POLD2', 'POLE3', 'USP1', 'FANCF']",0.9998617840333556,0,0,12
511,Integrated breast cancer pathway WP1984,0.9840949380640467,0.5820518688024409,0.009331982207891594,"['PLK3', 'JUN', 'GSK3A', 'GADD45A', 'BAD', 'ODC1', 'PHB', 'JAKMIP1', 'FOSL2', 'AR', 'E2F1', 'BAX', 'RAC1', 'FAU']",0.9998617840333556,0,0,14
512,MTHFR deficiency WP4288,0.9844728362667674,0.22833468319730857,0.0035732032200589924,['CYCS'],0.9998617840333556,0,0,1
513,Nanoparticle triggered autophagic cell death WP2509,0.9844728362667674,0.22833468319730857,0.0035732032200589924,['MAP1LC3A'],0.9998617840333556,0,0,1
514,Sphingolipid Metabolism (integrated pathway) WP4726,0.9844728362667674,0.22833468319730857,0.0035732032200589924,['CERS4'],0.9998617840333556,0,0,1
515,Endoderm differentiation WP2853,0.9852595030658966,0.531523642732049,0.00789324176419234,"['VAV3', 'DUSP4', 'MAD2L2', 'DUSP5', 'DUSP2', 'TRIM5', 'C1QBP', 'TCEAL2', 'SLC2A12', 'NME1']",0.9998617840333556,0,0,10
516,Thermogenesis WP4321,0.9862726487770352,0.5125976867771178,0.007085352074833426,"['ADCY10', 'CREB3', 'RPS6', 'ACTL6A', 'ACSL5', 'PPARG', 'HRAS', 'ACTB', 'ACTG1']",0.9998617840333556,0,0,9
517,MECP2 and Associated Rett Syndrome WP3584,0.9865218402131869,0.4275104537227735,0.005801237628052737,"['GPRIN1', 'RPS6', 'E2F1', 'TAP1', 'FKBP5']",0.9998617840333556,0,0,5
518,Interferon type I signaling pathways WP585,0.9876728314178573,0.35052325643291354,0.004347812784081938,"['RPS6', 'RAC1', 'EIF4B']",0.9998617840333556,0,0,3
519,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9893806353983641,0.34214628671197855,0.003652805915631255,"['GRIN3A', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,3
520,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9906942913243733,0.28184991273996507,0.002635092986801926,"['CXCL17', 'IFIT2']",0.9998617840333556,0,0,2
521,Glycerophospholipid Biosynthetic Pathway WP2533,0.9927237055156072,0.19173135630178806,0.0014001941230209062,['CDIPT'],0.9998617840333556,0,0,1
522,Ectoderm Differentiation WP2858,0.9937089869341148,0.4877765466957361,0.0030783016309036807,"['CDH6', 'SDCBP', 'PLCXD3', 'ARHGDIG', 'PIM1', 'SPRY2', 'JAKMIP1', 'CELSR2', 'MYORG', 'LY6E']",0.9998617840333556,0,0,10
523,Joubert Syndrome WP4656,0.9953232679671851,0.3737986020096112,0.0017522565141685307,"['TMEM17', 'KAT5', 'CETN2', 'ARL2', 'B9D2']",0.9998617840333556,0,0,5
524,Splicing factor NOVA regulated synaptic proteins WP4148,0.9959518897122525,0.24560343670291315,0.000996247622183721,"['CAV2', 'NCDN']",0.9998617840333556,0,0,2
525,Chemokine signaling pathway WP3929,0.9964257435419024,0.44803063457330417,0.0016042450916919594,"['SHC4', 'VAV3', 'GNG10', 'GNG3', 'PRKCD', 'RAC1', 'HRAS', 'PLCB2', 'MAPK3']",0.9998617840333556,0,0,9
526,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9965778860962748,0.2394415357766143,0.0008208014491341545,"['CYP27A1', 'DHCR24']",0.9998617840333556,0,0,2
527,Energy Metabolism WP1541,0.9965778860962748,0.2394415357766143,0.0008208014491341545,"['PPARG', 'MEF2D']",0.9998617840333556,0,0,2
528,BDNF-TrkB Signaling WP3676,0.9965903154717246,0.165225498894687,0.0005643294676580612,['HRAS'],0.9998617840333556,0,0,1
529,Pathways affected in adenoid cystic carcinoma WP3651,0.9968632066700809,0.2871933653426451,0.0009022821100504089,"['MORF4L1', 'CEBPA', 'HRAS']",0.9998617840333556,0,0,3
530,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9968632066700809,0.2871933653426451,0.0009022821100504089,"['DUSP2', 'STMN1', 'MAPK3']",0.9998617840333556,0,0,3
531,Hedgehog Signaling Pathway WP4249,0.9976657731369846,0.1545376531660172,0.000361147605760108,['EVC'],0.9998617840333556,0,0,1
532,Rett syndrome causing genes WP4312,0.9985317356849576,0.21273996509598603,0.00031258803626099267,"['IMPDH2', 'GABRD']",0.9998617840333556,0,0,2
533,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9987770050710901,0.40929040325101596,0.0005008664286463406,"['ABCG8', 'GYS1', 'GSK3A', 'THRA', 'PDPK1', 'LPL', 'PIK3C2G', 'HRAS', 'MAPK3']",0.9998617840333556,0,0,9
534,Fragile X Syndrome  WP4549,0.9990422900673532,0.4015664942023354,0.00038476849784529164,"['EEF1A1', 'GRIP1', 'GABRA1', 'DUSP3', 'PRKAR1A', 'CDKN2A', 'AKAP5', 'GABRD', 'AP2M1']",0.9998617840333556,0,0,9
535,DNA IR-damage and cellular response via ATR WP4016,0.999077937396379,0.2854461317864824,0.0002633206211822366,"['FEN1', 'E2F1', 'USP1', 'RAD9A']",0.9998617840333556,0,0,4
536,Ciliopathies WP4803,0.9996901880033996,0.4243212241686835,0.00013148017377902766,"['DNAH11', 'MKKS', 'DCDC2', 'PKD1L1', 'CFAP410', 'TMEM17', 'EVC', 'ARL2BP', 'CCDC65', 'B9D2', 'CCNQ', 'CCDC151', 'CCNO']",0.9998617840333556,0,0,13
537,Genes related to primary cilium development (based on CRISPR) WP4536,0.9997706244425513,0.30469796161285523,6.989828158359105e-05,"['MKKS', 'TMEM17', 'EVC', 'CDK20', 'TULP3', 'DYNLL1']",0.9998617840333556,0,0,6
538,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9998617840333556,0.10400273042719808,1.4375831427261083e-05,['TKFC'],0.9998617840333556,0,0,1
